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ABSTRACT 
 
        The actin cytoskeleton, composed of actin and its binding proteins, drives cell 
motility, determines cell shape, and is necessary for strong cell-matrix and cell-cell 
adhesion. Consistent with its critical function in cell physiology, actin assembly is highly 
regulated. One of the key factors controlling actin assembly is the actin nucleator, the 
Arp2/3 complex. Upon the hierarchical regulation of the activity of the Arp2/3 complex, 
the cell can build the control actin framework spatially and temporally in response to 
different cellular signals. Understanding the molecular mechanism of how Arp2/3 is 
regulated would provide crucial insights into how actin polymerization is normally 
controlled to direct cell movements. It will also provide insights into how misregulation 
of actin assembly can cause disease such as metastasis. Even though many factors have 
been shown to contribute to Arp2/3 dependent actin assembly, these known factors are 
not sufficient to account for Arp2/3 mediated actin assembly detected in cells, implying 
there are still missing factors that contribute to this reaction. The bacterial pathogen 
Listeria monocytogenes, for example, uses host Arp2/3 to assemble an actin comet tail. 
We used Listeria as a tool to screen brain cytosol for new factors that promote comet tail 
assembly. We identified Collapsin Response Mediator Protein-1 (CRMP-1) as a new 
factor for Arp2/3 dependent actin polymerization. CRMP-1 is essential for Listeria 
monocytogenes actin tail formation, as well as for actin filament accumulation inside 
MDCK epithelial cells. CRMP-1 acts as an enhancer for Arp2/3 complex in the Listeria 
system; yet CRMP-1 works with EVL as a novel Arp2/3 activator in the mammalian 
system. Perturbing CRMP-1 function results in the loss of actin assembly in both systems. 
CRMP-1 belongs to CRMP family which has been long studied as a microtubule binding 
protein. Our results reveal that this family protein might help the crosstalk between actin 
and microtubule cytoskeleton. 
 
 
 
 
 
iii 
 
 
 
 
 
 
 
 
 
To my husband Jim, our son Jimmy, and our families. 
獻給我最親愛的家人 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
Acknowledgement 
 Thanks to my thesis adviser, Dr. William Brieher, for giving me the chance to 
work on the CRMP-1 project and for his support along the way. 
 Many thanks to my thesis committee, Dr. Martha Gillette, Dr. Claudio Grosman, 
and Dr. Phillip Newmark, as well as past committee members, Dr. Michel Bellini 
and Dr. Fei Wang, for providing suggestions for both my project and my career.  
Special thanks to Dr. Newmark and Dr. Gillette, who were willing to spare some 
time from their busy schedules to meet with me whenever I felt lost; thank you for 
lightening hope on pursuing a research career.  Special thanks to Dr. Grosman and 
Dr. Bellini, with whom I had many delightful conversations about different 
further possibilities. 
 
        My Ph.D. is like running a marathon, without being able to reach the finish line.  
Whenever I thought I got close, the line got pushed farther away.  I would not have been 
able to maintain my strength to endure this process without the love and support from my 
family, and my friends.  
        I am grateful to have my husband, James Kemp, to be on my side with my every 
mood.  I cannot thank him enough for his endless patience toward me and his strong 
belief in humanity.  With so many obstacles in my Ph.D., having his love and support are 
the reason why I can smile even when the times were hard.   
        I am blessed to have my family’s support.  To my family in Taiwan, sorry for my 
absence for all the years.  The messages and phone calls from you always cheer me up.  
To my family in U.S.A., thank you for always being there whenever I need help.  To my 
son, Jimmy, I am so glad to have you. You bring joys to my life and color my Ph.D.  
        I am very lucky to meet and make friends with many loving people.  Among them, I 
would like to emphasize my gratitude to my best friends, Koh Eun Narm and Christina 
Rosenberger.  Thank you for listening to me and empathizing with my feelings.  The 
sarcastic response from Koh Eun always made me laugh about my own situation; the 
optimistic attitude from Christina drove me through many down times.  The time we 
shared together are one of the best memories I cherish in my Ph.D. 
v 
 
        I am also thankful for some of the not ideal situations I encountered during these 
years, which strengthened me and pushed me to think over many things I would have 
never thought of. The unpleasant experience with the people I met in science taught me 
the importance of treating people kindly and politely, and the importance of being a 
helpful labmate or a respectful senior scientist.  Many thanks to the labmates, Kieran 
Normoyle, James Kemp and Krista Angileri, who always generously provide their know-
how and offer help to those in need, and Ambika Nadkarni, whose bright spirit brings 
laughs to the lab.  If I had a chance to restart my Ph.D in 2009, I might have chosen a 
different path. But if that were the case, I would not have experienced the same, and 
would not met these people who helped me grow and helped me realize that I am so 
loved and supported.   
 
vi  
Table of Contents 
 
CHAPTER 1: INTRODUCTION ....................................................................................... 1 
I. Actin and Actin Cytoskeleton ...............................................................................1 
II.  Arp2/3 Complex and Nucleation Promoting Factors............................................2 
III.  Cadherin Mediated Adherens Junction .................................................................5 
IV.  Listeria monocytogenes ........................................................................................6 
V.  Collapsin Response Mediator Protein (CRMP) Family Proteins .........................8 
i. Overview .............................................................................................................. 8 
ii. The CRMP variants.............................................................................................. 9 
iii. The varied functions of CRMP variants ............................................................ 10 
iv. CRMPs and cytoskeleton ................................................................................... 11 
v. Post-translational modification of CRMPs ........................................................ 13 
vi. Sequence and the related function of the CRMPs ............................................. 15 
 
CHAPTER 2: MATERIAL AND METHODS................................................................. 19 
I.  Plasmids and Sequence .......................................................................................19 
i. Plasmids ............................................................................................................. 19 
ii. Sequence ............................................................................................................ 19 
II. Protein Purification .............................................................................................20 
i. Purification of CRMP-1 from brain cytosol ...................................................... 20 
ii. Recombinant protein purification ...................................................................... 21 
iii. Endogenous protein purification ........................................................................ 21 
 
 
 
vii  
 
 
III.  Biochemical Assays ............................................................................................22 
i. Listeria preincubation assays ............................................................................. 22 
ii. Immunodepletion of CRMP-1 and rescue experiments ..................................... 22 
iii. In vitro actin assembly assays ............................................................................ 23 
iv. Filament branching assay ................................................................................... 24 
v. F-actin co-sedimentation .................................................................................... 24 
vi. Protein interaction assays ................................................................................... 24 
IV. Tissue Cultured Cells and Imaging .....................................................................26 
i. Cell line .............................................................................................................. 26  
ii. Calcium switch assay ......................................................................................... 26 
iii. Fixation and staining .......................................................................................... 26 
iv. Hanging drop adhesion assays ........................................................................... 27 
v. Cell spreading experiment ................................................................................. 28 
vi. Wound healing experiment and live cell imaging ............................................. 28 
V. Data analysis .......................................................................................................28 
 
CHAPTER 3: RESULTS .................................................................................................. 30  
I. CRMP-1 contributes to Listeria Actin Tail Formation .......................................30 
i.  Identification of CRMP-1 as a new factor for Listeria actin tail formation ...... 30 
ii.  CRMP-1 is essential for Listeria Actin Tail Formation..................................... 30 
iii.  CRMP-1 and CRMP family proteins facilitate Arp2/3-dependent assembly .... 32 
iv.  CRMP-1 increases Arp2/3-dependent branching .............................................. 34 
 
 
viii  
 
 
II. Localization and Functional Study of CRMP-1 at Cadherin-Mediated Adherens 
Junction in MDCK Cells ................................................................................................34 
i. CRMP-1 locates at cadherin-mediated cell-cell contacts .................................. 34 
ii. CRMP-1 is recruited to cell-cell contact at the early stage of the contact re-
formation ............................................................................................................ 35 
iii. Depletion of CRMP-1 reduces cadherin and F-actin amount at the apical 
junction .............................................................................................................. 36  
iv. Reduced stress fiber was detected in the CRMP-1 knockdown cells ................ 36 
v. CRMP-1 knockdown cells share similar many attributes with the Arp2/3 
knockdown MDCK cells.................................................................................... 37 
vi.  Arp2/3 might be less active under the CRMP-1-knockdown background ........ 38 
vii. CRMP-1 highly associates with cadherin-enriched membrane fraction and 
contributes to de novo Arp2/3 polymerization in the purified liver membrane 
system ................................................................................................................ 39 
viii. CRMP-1, rather than using VCA fragment of WAVE, works with EVL to 
activate Arp2/3 complex .................................................................................... 41 
ix.  EVL and CRMP localize to cadherin mediated junction and mediate junctional 
actin assembly .................................................................................................... 43 
x. Depletion of CRMP-1 or EVL decrease cell-cell attachment and reduces the rate 
of junction formation ......................................................................................... 45 
 
 
 
 
 
 
ix  
 
 
III. Localization and Functional Study of CRMP-1 in Lamellipodia .......................46 
i. CRMP-1 locates to the leading edge of protrusive structures in MDCK cell .... 46 
ii. CRMP-1 is essential for cell spreading in an Arp2/3-dependent manner .......... 46 
iii. CRMP-1 contributes to F-actin accumulation at the leading edge of lamellipodia 
of a wounded cell ............................................................................................... 47 
iv. No obvious change in microtubule organization was detected in CRMP-1-
depleted or –overexpressing cells ...................................................................... 48 
v. Semaphorin 3A does not attenuate the formation of the protrusive structures in 
MDCK cells ....................................................................................................... 49 
vi. CRMP-1 contributes to the stability of the protrusive edge .............................. 50 
vii. CRMP-1 contributes to the directionality in wounded monolayers................... 50 
CHAPTER 4: DISCUSSION ............................................................................................ 52  
CHAPTER 5: REFERENCES .......................................................................................... 56 
CHAPTER 6: FIGURES................................................................................................... 68  
APPENDIX A ................................................................................................................. 106 
APPENDIX B ................................................................................................................. 118 
 
1 
 
CHAPTER 1: INTRODUCTION 
I. Actin and Actin Cytoskeleton 
        Actin is a protein containing 375 residues. It is one of the most abundant proteins 
inside the cell. It polymerizes into long filaments that organize into networks to form the 
actin cytoskeleton. The actin cytoskeleton is a dynamic structure, that is constantly be 
assembled, disassembled, and reassembled in response to internal and external signals.  A 
collection of dozens perhaps hundreds of actin binding proteins control actin organization 
to perform diverse cellular processes, such as cell migration, cytokinesis, and endocytosis 
as well as an important structural role in reinforcing cell-matrix and cell-cell adhesive 
contacts. 
        Actin can exist in a globular monomeric form (G-actin) and as filamentous form (F-
actin) inside the cell. In vitro, under low salt condition, actin remains in its monomeric 
state. Upon the addition of ions, G-actin can self-assemble into F-actin. This process is 
called polymerization. Polymerization can be further divided into a nucleation phase and 
an elongation phase. The nucleation phase is slow because the actin subunits must first 
form an actin trimer in order for actin to then polymerize; yet this trimer state is unstable. 
Therefore, a kinetic barrier of actin polymerization is usually seen as a long lag phase 
before fast actin assembly begins.  
        Cells express actin nucleation factors, such as the Arp2/3 complex, which can help 
bypass the barrier by structurally mimicking the trimeric state of actin, therefore actin 
filaments can be generated rapidly provided an active actin nucleation factor is present 
(see the next chapter). After nucleation, the filament can be elongated by just adding actin 
monomers to the end of the existing filament. This process is very fast relative to 
nucleation. During elongation, new actin monomers are added only to one end of the 
filament. We call this end the growing end, or the plus end. The other end is called the 
shrinking end, or the minus end. This polarity of actin filament results from the consistent 
orientation of all the monomers within the polymer such that they all face the same 
direction (Fujii et al., 2010).  
        Opposite to polymerization, F-actin can be disassembled (depolymerized) into G-
actin. Disassembly usually takes place at the minus end of the filament. Polymerization is 
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essential for the actin cytoskeleton to perform its function in many situations, (see 
examples in Chapter 1, III and IV). Depolymerization, therefore, ensures the turnover of 
actin filaments and maintains a substantial pool monomeric actin that allows continual 
growth of the actin filaments. 
       The actin cytoskeleton has two major structural arrangements inside the cell: the 
filaments are either organized into branched actin networks or they are crosslinked into 
parallel bundles. In the branched networks, the minus end of one actin filament is 
anchored to the side of another filament through the Arp2/3 complex (see the next 
chapter). In the bundled situation, actin filaments are aligned in a parallel array through 
the side binding activity of various actin bundling proteins, such as vasodilator-stimulated 
phosphoprotein (Ena/VASP), alpha-actinin and fascin (Honda et al., 1998; Kane, 1975; 
Reinhard et al., 1992). During cell migration, the leading edge can contain two kinds of 
protruding structures, lamellipodia and filopodia, which consist of branched arrays and 
parallel bundles of filaments, respectively (Yang and Svitkina, 2011a; Yang and Svitkina, 
2011b). Despite the distinct F-actin organizations of lamellipodia and filopodia, the two 
structures might be dynamically interrelated. Their filaments may be generated by 
common nucleator(s), since electron microscopy study indicates that the reorganization 
of dendritic network in the lamellipodia can be bundled together to form filopodial 
structure (Svitkina et al., 2003). Branched and bundled actin networks were also detected 
in the actin cytoskeleton formed by the pathogen Listeria monocytogenes. Understanding 
how the different organizations are formed is one important topic in order to understand 
how cell regulates the actin cytoskeleton. 
 
II.  Arp2/3 Complex and Nucleation Promoting Factors 
        Cells use the branched actin network at different cellular locations to perform 
different functions: at the leading edge of motile eukaryotic cells to push the membrane 
forwards (Svitkina and Borisy, 1999; Svitkina et al., 1997), at adherens junction to 
establish and maintain cell-cell adhesive contacts (Kovacs et al., 2011; Verma et al., 
2012), and at the surface of certain pathogens like Listeria for its invasion and 
intracellular movement (Cossart, 2000; Welch and Way, 2013). 
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        The formation of the branched network requires a protein complex called the Arp2/3 
complex (Pollard and Beltzner, 2002; Pollard and Borisy, 2003). Arp2/3 is often referred 
to as an actin nucleator, since it can rapidly generate new filaments. The key mechanism 
to forming a dendritic meshwork relies on the binding of Arp2/3 complex to the side of a 
preexisting filament (mother filament), followed by initiating a new filament (daughter 
filament) with angle of 70 on the side of the old filament (Mullins et al., 1998). The 
Arp2/3 complex consists of seven subunits, Arp2, Arp3, p16, p20 (ARPC4), p21 
(ARPC3), p34 (ARPC2), and p40 (ARPC1). Among all the subunits, p20, p34 and p40 of 
Arp2/3 contact the mother filament. Subunits Arp2 and Arp3 contact the daughter 
filament. Subunits Arp2 and Arp3 form a pocket to accommodate new actin monomers, 
therefore initiating the growth of the new filament. This pocket also provides the 
anchoring site for the pointed end of the daughter filament after the filament is formed. In 
the inactive state, the Arp2 and Arp3 subunits are too apart from each other and therefore 
structurally unfavorable to incorporate an actin monomer. It has been shown that various 
molecules need to contribute to the activation of Arp2/3 complex, including ATP, 
binding to the mother filament, and binding to nucleation promoting factors (NPFs) 
(Goley et al., 2004; Rouiller et al., 2008; Zencheck et al., 2009).  
        To grow a new filament out of the mother filament, several conformational changes 
have been detected during this process. Interestingly, those conformational changes are 
not limited to the Arp2/3 complex. Actin molecules in the mother filament also undergo 
several conformational changes. It is thought that those conformational changes result in 
the reinforcement of the interface between Arp2/3 and the mother filament, leading a 
strong(er) anchoring for the daughter filament (Rouiller et al., 2008). Therefore, the 
filament can exert force to push a membrane outward or to push a pathogen forward. A 
conformational change on Arp2/3 was observed upon ATP binding. As a result, the 
spatial distance between Arp2 and Arp3 gets narrower (Goley et al., 2004; Rouiller et al., 
2008). Arp2/3 also adjusts its conformation while contacting the mother filament. After 
Arp2/3 binds to the mother filament, NFP helps recruit the first monomeric actin to Arp2-
Arp3 pocket, establishing a template for the elongation of the branched daughter filament. 
Upon this branching formation, Arp2/3 complex and the mother filament adapt their 
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conformation at the contacting interface to reinforce and stabilize the branching structure 
(Rouiller et al., 2008). 
        The cell regulates the formation of new Arp2/3 dependent filaments through NPFs. 
The most well-known NPFs inside the cells are the Wiskott-Aldrich syndrome protein 
(WASP) family of proteins and the WASP family verprolin-homologous protein 
(Scar/WAVE or WAVE). NPFs themselves require activation through upstream signaling, 
which therefore provide cells with a mechanism for the spatial and temporal regulation of 
Arp2/3 activity and actin nucleation. The major signaling pathways involve the small G 
proteins Cdc42 and Rac. Cdc42 activates neural (N)-WASP (Rohatgi et al., 1999); Rac 
activates WAVE (Eden et al., 2002).  
        WASP and WAVE contain a VCA domain that binds and activates Arp2/3. To be 
more specific, WASP contains two V regions. So it is often referred to as the VVCA 
region for the WASP protein, whereas VCA is for WAVE. The V (verprolin homology) 
sequence, (also called the WASP homology 2 (WH2) domain), binds actin monomers; 
the C (central, connecting, or cofilin homology) sequence and A (acidic) sequence 
interacts with and activates Arp2/3 (Pollard and Borisy, 2003).  
        Even though NPFs are viewed as Arp2/3 activators in general, they could have other 
functions. Sometimes different NPFs colocalize in cell yet each NPF plays a distinct role. 
For example, N-WASP and WAVE are both localized to adherens junction (Ivanov et al., 
2005) and in lamellipodia (Nakagawa et al., 2001). At the adherens junction, WAVE-2 
activates Arp2/3 (Verma et al., 2012), whereas N-WASP regulates and maintains 
junctional filament stability rather than actin nucleation (Kovacs et al., 2011). Inside 
lamellipodia, N-WASP seems to control the formation of actin bundles, in addition to its 
activation activity on the Arp2/3 complex (Nakagawa et al., 2001).  
        Besides WASP and WAVE, which are the canonical VCA/VVCA-domain-
containing NFPs, other proteins were also identified that activate or co-activate the 
Arp2/3 complex in a non-canonical fashion. Those molecules include, but are not limited 
to, cortactin and Dip1 (Wagner et al., 2013; Weaver et al., 2001). Revealing the 
mechanism of how different NPFs function independently and cooperatively is the key to 
understand how a cell effectively activates and controls Arp2/3 in response to various 
cellular environments and signals. 
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III.  Cadherin Mediated Adherens Junction 
        Cadherin-mediated adherens junctions are a type of cell-cell contact mediated by 
cadherin molecules along the apical-lateral surface of the neighboring plasma membranes. 
This junction is important during embryonic development, cell growth, cell migration, 
differentiation, and even cancer cell invasion (Christofori and Semb, 1999; Takeichi, 
1993).  Cadherin mediated cell-cell junctions are also required for maintaining strong 
cell-cell adhesion throughout life. In certain epithelia, such as in Caco 2 cells, the 
adherens junction is highly developed with the vast majority of the cadherin concentrated 
in an “adhesion belt” that forms around the border of the contacting cells. The cadherins 
in the belt colocalize with a prominent ring of F-actin lining just beneath the cadherins. 
This highly specialized form of cadherin dependent contacts is called the “zonula 
adherens” (Verma et al., 2012). In other cell types, adherens junction display different 
morphologies: spotty and discontinuous more mesenchymal cells and in epithelial 
MDCK cells (Yonemura et al., 1995), or as tiny puncta as a constituent of the synaptic 
junctions in neurons (Uchida et al., 1996). 
        To form cadherin-mediated cell contacts, cadherins use their N-terminal 
extracellular domain to form hemophilic interactions with an identical cadherin isoform 
extending from an adjacent cell to connect the neighboring cells in a calcium-dependent 
manner. The cytoplasmic tail of cadherin provides anchoring sites for cytoskeletal 
elements, such as different catenins (Kemler, 1993). Cadherin recruits beta-catenin, 
which in turn binds alpha-catenin; and thus, it has been thought that cadherin can be 
passively linked to the actin filament through alpha-catenin (Jou et al., 1995). Yet later 
researches debate whether or not those interactions are mutually exclusive. Some said 
that cadherin-catenin complexes cannot bind actin (Drees et al., 2005; Yamada et al., 
2005); whereas others presented data showing this interaction would exist only under 
tension (Buckley et al., 2014). Other than catenins, there are multiple different 
mechanisms that could provide the linkage between cadherin and F-actin. For example, 
cadherin (E-cadherin) can associate with the Arp2/3 complex, the actin nucleator (Kovacs 
et al., 2002; Kovacs and Yap, 2002). Cadherins therefore also have an active influence in 
the formation of actin filaments at cell-cell contacts. Different pharmacological agents 
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that interfere the actin cytoskeleton, such as cytochalasin D and latrunculin, can rapidly 
and efficiently disrupt adherens junctions, indicating the crucial role of actin cytoskeleton 
to cell-cell contact integrity. It is believed that the actin cytoskeleton provides mechanical 
force to maintain and reinforce cell-cell contacts (Vasioukhin et al., 2000). Many factors 
have been shown contribute to the formation of actin network at the junction. 
Understanding the mechanism and the relationship of those factors would not only help 
us understand the regulatory pathway of adherens formation, but also provide 
pharmaceutical input on diseases such as cancer. 
 
IV.  Listeria monocytogenes 
        Listeria monocytogenes (Listeria) is a gram-positive food-borne pathogen. Listeria 
can tolerate a wide range of pH and temperatures; therefore it can survive in refrigerated 
and even pasteurized food. Ingestion of contaminated food can lead to gastrointestinal 
symptoms or even lysteriosis.  
        The virulence of Listeria relates to its ability to transmit from cell to cell. After 
entering the cell, Listeria multiplies and is encapsulated by actin filaments. Those actin 
filaments later organized and extended to form an actin comet tail. Comet tail assembly 
creates the propulsive force for Listeria’s intracellular movement. Using this actin tail, 
Listeria can then translocate and spread into the adjacent cells (Sanger et al., 1992; Tilney 
and Portnoy, 1989). 
        This actin-based motility of Listeria requires one Listeria membrane protein, ActA. 
This surface protein mimics the function of cellular NPFs. ActA contains an acidic 
domain and a cofilin homology domain at its N-terminus; ActA hence binds and activates 
the Arp2/3 complex (Cossart, 2000; Welch et al., 1997). ActA can also recruit other 
cellular protein, such as Ena/VASP family proteins. Ena/VASP uses its EVH1 domain to 
bind to the proline-rich domain of ActA, and its EVH2 domain to bind to F-actin. It has 
been believed that Ena/VASP proteins contribute to Listeria actin tail growth by 
enhancing the contact and the elastic linkage of the bacteria to the actin filaments 
(Laurent et al., 1999; Skoble et al., 2001; Suei et al., 2011). Despite the unknown details 
of Listeria propulsion, ActA clearly recruits factors from the host to trigger actin 
assembly at the bacterial surface. 
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        Many other actin-binding proteins also have roles in this actin comet tail. For 
instance, cofilin is necessary for depolymerizing the tail therefore controlling the tail 
length (Rosenblatt et al., 1997). Interestingly, a protein usually shares a similar function 
for the Listeria actin tail and for actin networks found inside the cell, which indicates that 
Listeria actin comet can be used as a model system for understanding other actin arrays 
used by the cell. The Listeria actin comet tail has other characteristics that are similar to 
the cellular actin systems: the rate of this tail assembly equals the rate of actin 
polymerization (Theriot et al., 1992), and the structure of the actin filaments: the comet 
tail contains a branched meshwork and/or paralleled bundles, which is similar to the actin 
organization detected in protruding lamellipodia and filopodia (Brieher et al., 2004). This 
structural similarity supports the notion that Listeria is driven by the same machinery 
responsible for the protrusion structures of a mirgrating cell (Borisy and Svitkina, 2000). 
Because of all those key resemblances, people have used Listeria as a model system for 
the in vitro study of the actin cytoskeleton. Listeria has been used to characterize proteins 
with actin-related function (David et al., 1998; Welch et al., 1997), examine the 
organization of the actin network (Brieher et al., 2004) and investigate the turnover of 
actin arrays (David et al., 1998; Rosenblatt et al., 1997). 
        A more recent publication from Van Troys and colleagues revealed the complexity 
of the proteins in the Listeria actin tail using proteomic techniques (Van Troys et al., 
2008). Many of the proteins identified in their screen have no known actin-related 
functions, implying that this actin tail system might be far more sophisticated than we 
thought, in terms of participating components and regulatory pathways. In addition, 
independent researches mentioned that the reconstituted actin comet tail built out of 
purified components could be less efficient than the one formed in complex cytosol 
(Brieher et al., 2004; Laurent et al., 1999; Welch et al., 1997). Our knowledge on this 
actin tail might limited to the minimal components yet not the whole machinery. My 
Ph.D. project aims to characterize proteins that are novel for the Listeria tail formation, 
and follow with a mechanistic study of the protein in vitro and the functional study of the 
protein inside the cell. This project was initiated by my Ph.D. advisor William M. Brieher. 
He established an approach that combines unbiased chromatography and Listeria to 
screen through the potential factors from bovine brain cytosol that contribute to comet 
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tail assembly (Brieher et al., 2004). Using his method, he discovered Collapsin Response 
Mediator Protein-1 (CRMP-1) as one factor enhancing Listeria actin tail formation.  
CRMP-1 was a surprise as it had never been considered as an actin assembly factor in the 
past. My PhD project was to critically evaluate whether or not CRMP-1 actually 
contributes to Arp2/3 dependent actin assembly. 
 
V.  Collapsin Response Mediator Protein (CRMP) Family Proteins  
i. Overview 
        The CRMP family consists of five family members in vertebrates: CRMPs 1-5 (Byk 
et al., 1996; Gaetano et al., 1997; Goshima et al., 1995; Inatome et al., 2000; Minturn et 
al., 1995b).  The CRMP family is highly homologous to the enzyme dihydropyrimidinase 
(DHPase).  However, CRMP proteins lack a key amino acid in the active site necessary 
for enzymatic activity.  C. elegans and Drosophila express only one CRMP gene, which 
will produce one CRMP and one DHPase through alternative splicing (Morris et al., 
2012). The function of CRMP family protein was first mentioned in 1985 by Hedgecock 
and colleagues (Hedgecock et al., 1985). They found that unc-33, the homolog of human 
CRMP-2 and chick CRMP-62, contributes to axon growth in Caenorhabditis elegan. 
Goshima and colleagues later identified vertebrate chick CRMP-62 as a component for 
transduction pathway of the extracellular semaphorin 3A (Sema3A) signal (Goshima et 
al., 1995). Sempahorin 3A is an important axon guidance cue in the developing nervous 
system.  When applied to neuronal growth cones, it causes the growth cone to collapse.  
CRMP-62 got its name because it was required for collapse, hence “Collapsing Response 
Mediator Protein”.  The work done Goshima that identified chicken CRMP-62 is the 
same as CRMP-2.  Since then, the vast majority of CRMP researcher has been focused on 
studying CRMP-2 and how it regulates various aspects of axon pathfinding and neurite 
outgrowth (Goshima et al., 1995; Hedgecock et al., 1985; Inagaki et al., 2001; Minturn et 
al., 1995b; Quinn et al., 2003; Quinn et al., 1999; Siddiqui and Culotti, 1991; Yoshimura 
et al., 2005).  
          Researchers are interested to know how CRMP family proteins achieve their 
physiological function. The very early study by Hedgecock et al. described that mutation 
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of unc-33 causes disruption of microtubule organization and abnormal microtubule 
structure in the neuronal cells, but not in muscle or hypodermal cells (Hedgecock et al., 
1985). They proposed thought unc-33 can bind to microtubules and control the assembly 
or stability of neuronal microtubules. Subsequent biochemical and cell biological work 
successfully detected that CRMP-2 binds tubulin and promotes microtubule growth.  Not 
until the early 2000s did the studies on CRMPs start to reveal their possible involvement 
in actin. With more and more studies published, we now know that CRMPs can bind both 
actin and microtubules, CRMPs function in various cell types (not just neuronal cells), 
and CRMPs are post-translationally modified in response to various cellular demands. 
ii. The CRMP variants 
        After the discovery of chick CRMP-62 (CRMP-2) as a factor for Sema3A-mediated 
signaling (Goshima et al., 1995), a whole family of cytoplasmic proteins was described to 
be involved in the same signal transduction cascade. This family is now called 
collapsin response mediator protein (CRMP), which has replaced older names as turned 
on after division (TOAD) (Minturn et al., 1995a; Minturn et al., 1995b), or Unc-33-like-
phosphoprotein (Ulip) (Byk et al., 1996; Byk et al., 1998; Gaetano et al., 1997). CRMP is 
also often referred to as DHPase-related protein due to its high sequence homology and 
structural similarity to DHPase (Goshima et al., 1995; Hamajima et al., 1996). The key 
distinction between DHPase and CRMP is that CRMP does not carry the enzymatic 
activity as DHPase (Goshima et al., 1995). DHPase is zinc-coupled dihydropyrimidine 
hydrolases; CRMPs lack this hydrolase activity as well as one or more zinc-binding site 
residues found in DHPase (Hamajima et al., 1998; Takemoto et al., 2000; Wang and 
Strittmatter, 1996). 
        The CRMP family was once consisted of four members: CRMP-1, -2, -3 and -4 
(Quinn et al., 1999). Relatively recently, a new member CRMP-5, also called CRAM 
(CRMP3-associated molecule) or unc33-link phosphoprotein 6, was identified by 
different groups (Fukada et al., 2000; Horiuchi et al., 2000; Inatome et al., 2000). Unlike 
CRMPs 1-4 which share ~70-85 identity in sequence, CRMP-5 shares ~50% sequence 
identity with CRMPs 1-4 and DHPase. 
        The complexity of the CRMP family was further extended in 2003 by Yuasa-
Kawada and colleagues (Yuasa-Kawada et al., 2003). They described the alternatively 
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spliced isoforms for several CRMPs (1, 2, and 4). The original isoform is now referred to 
as short isoform CRMP (S-CRMP) or CRMPa; the variant with a longer N-terminus is 
now called long isoform CRMP (L-CRMP) or CRMPb (Alabed et al., 2007; Pan et al., 
2011; Quinn et al., 2003; Yuasa-Kawada et al., 2003). Researches on the functional 
difference between the two isoforms showed that different isoforms might perform 
different functions; sometimes one isoform can be an antagonist against the function of 
another isoform (see later chapters). In my thesis, the CRMP-1 I studied is the short 
isoform. 
iii. The varied functions of CRMP variants 
1. Different CRMP homologous 
        Emerging evidence shows that different CRMPs and different CRMP isoforms can 
have different or even antagonist functions. For example, even though CRMP-1 and 
CRMP-2 both contribute to neuronal outgrowth, they function differently in growth cone 
steering. Irradiation of CRMP-1 in the half region of the growth cone causes the growth 
cone turning away from the irritated site. In contrast, the growth cone turned toward the 
irritated site while inactivating CRMP-2 (Higurashi et al., 2012). This result shows that 
despite their high sequence homology, the members in the CRMP family might work 
through distinct mechanisms or different pathways.  
       Another example for the antagonistic effects among CRMPs can be found in the 
literature describing the conflicting function of CRMP-5 to other CRMPs. CRMP-5 
showed the opposite function to other CRMP homologs. The binding of CRMP-2 to 
tubulin promotes neurite outgrowth; yet CRMP-5 can act as dominant signal and abrogate 
the outgrowth effect from CRMP-2 by antagonizing the tubulin-CRMP-2 interaction 
(Brot et al., 2010). Note that this counter-effect seems to involve a pathways that 
excludes the direct molecular interaction between CRMP-2 and CRMP-5. CRMP-1 and 
CRMP-5 are also shown to have antagonistic effects. CRMP1 stimulates the proliferation 
of neuronal progenitors, while CRMP-5 has negative effects (Veyrac et al., 2011). In 
other conditions, CRMP-5 helps filopodia extension in growth cone even in the presence 
of Sema3A (Hotta et al., 2005), yet other CRMPs, at least CRMP-1 and CRMP-2, 
function downstream of Sema3A (Uchida et al., 2005). 
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2. Different isoforms 
       Different splice variants of a CRMP can also have opposite cellular functions. L-
CRMP-1 enhances filopodia formation, cancer cell migration and invasion via 
stabilization of actin; yet S-CRMP-1 has the opposite effect (Pan et al., 2011). L- and S-
CRMP-2 can both bind to the kinase ROCKII. L-CRMP-2, however, has an extra 
ROCKII binding site at it N-terminus, which allows L-CRMP-2 to preferably bind to 
ROCKII and inhibit ROCK-dependent carcinoma cell migration and fibronectin matrix 
assembly (Yoneda et al., 2012). Similarly, L-CRMP-4 uses its unique N-terminal region 
to provide a better binding to its binding partner RhoA. Both of the isoforms of CRMP-4 
bind RhoA; yet L-CRMP-4 shows a more robust binding to RhoA than S-CRMP-4 
(Alabed et al., 2007; Alabed et al., 2010). In addition, only the L-CRMP4 isoform shows 
GSK3β- or Nogo-regulated RhoA binding, even though the regulation of GSK3β affects 
phosphorylation of both S- and L-CRMP-4 (Alabed et al., 2007).  
iv. CRMPs and cytoskeleton 
1. CRMPs and microtubule dynamics 
        CRMP-2 is the first described and most studied member of this family (Goshima et 
al., 1995). Its studies started on investigating its role in neuronal outgrowth and collapse. 
CRMP-2 can regulate neuronal polarity and axon elongation (Yoshimura et al., 2005). 
Overexpression of CRMP-2 in hippocampal neurons induces the formation of multiple 
axons for promotes elongation of the primary axon (Inagaki et al., 2001). On the other 
hand, CRMP-2 also contributes to growth cone collapse. This opposite effects of CRMP-
2 can be explained by its tubulin binding ability and its post-translational modifications. 
Unphosphorylated CRMP-2 binds directly to tubulin dimer (Fukata et al., 2002). CRMP-
2 also also binds to the kinesin-1 light chain, therefore regulates the transport of soluble 
tubulin to the distal parts of growing axon (Kimura et al., 2005). The binding of CRMP-2 
to tubulin would be disrupted when CRMP-2 is phosphorylated in response to repulsive 
guidance cue, Sema3A (Goshima et al., 1995). Other CRMP family protein, such as 
CRMP-5, was also shown to bind to tubulin. However, instead of functioning as a 
downstream regulator for Sema3A to affect axon morphology, CRMP-5 inhibits axon 
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outgrowth by binding to tubulin itself and preventing the tubulin-CRMP-2 interaction 
(Brot et al., 2010). 
        Other than their roles in the neuronal cells, CRMPs contribute to other cellular 
functions through binding to microtubules. For example, CRMP-2 has been detected in 
the mitotic spindle of transformed mouse and human cells (Tahimic et al., 2006). It binds 
to tubulin during mitosis and can regulate mitosis and mitosis duration (Lin et al., 2011; 
Oliemuller et al., 2013; Tahimic et al., 2006). Perturbing CRMP functions results in 
multinucleated cells and causes apoptosis in A549 non-small-cell lung cancer (NSCLC) 
(Oliemuller et al., 2013). 
2. CRMPs and actin cytoskeleton 
        The first direct evidence showing the direct interaction between CRMP and actin 
was published in 2005: CRMP-4 can bundle F-actin in vitro (Rosslenbroich et al., 2005). 
A later study using truncational analysis revealed that CRMP-4 uses its C-terminus to 
bind F-actin (Khazaei et al., 2014). Even though not many in vitro biochemical studies 
have been done to further dissect the molecular mechanism of CRMPs on actin dynamics, 
independent groups have observed the localization of CRMPs to actin-related structures.  
        Evidence showing CRMPs locate to the actin cytoskeleton could be traced back to 
the early growth cone researches. Early work emphasized the role of CRMPs in 
regulating growth cone collapse through modulating microtubule dynamics. Yet the 
growth cone staining indicates endogenous CRMP localizes to the very tip of the growth 
cone, which is organized by the actin cytoskeleton, not microtubules (Arimura et al., 
2005; Minturn et al., 1995a; Nishimura et al., 2003). Not until recently, have researchers 
started to discuss the localization of CRMPs to actin structures in growth cones. CRMP-1, 
for example, overlaps with actin in the growth cones of dorsal root ganglion (DRG) 
neurons (Higurashi et al., 2012).  
        Growth cone collapse can be an downstream effect of actin bundle loss, actin 
redistribution or through actin depolymerization (Zhou and Cohan, 2001). CRMPs could 
possibly cause the loss of actin bundles through different ways. CRMP-1 was recently 
reported to bind to filamin-A, which is a known actin bundling protein. Sema3A 
signaling may augment the CRMP-filamin interaction and thus attenuate the ability of 
filamin to crosslink F-actin into bundles (Nakamura et al., 2014). Furthermore, CRMP 
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binds to another known regulator of actin dynamics in neurons known as MICAL. 
MICAL directly binds F-actin and disassembles both individual and bundled actin 
filaments. MICAL alone, however, is autoinhibited. CRMP is thought to release the auto-
inhibition of MICAL (Schmidt et al., 2008). CRMP can therefore link Sema3A signaling 
from Plexin, the receptor for Sema3A, to F-actin disassembly through MICAL (Hung et 
al., 2010; Terman et al., 2002). It is unclear if the actin bundling activity of CRMP would 
be altered after post-translational modification. Even though the Kaibuchi group 
mentioned that phosphorylation or un-phosphorylated CRMP-2 can pull-down the same 
amount of actin from cell extract (Arimura et al., 2005), a more careful quantitative assay 
needs to be done to support this statement.  
        Other actin-related functions for CRMPs have been mentioned in the literatures. 
CRMPs were detected in filopodia, suggesting their role in regulating filopodial 
dynamics and/or growth cone development: CRMP-4 for filopodial extension in 
hippocampal neurons (Khazaei et al., 2014); CRMP-5 for filopodia growth in mouse 
DRG neurons (Hotta et al., 2005); L-CRMP-1 for filopodia formation in NSCLC (Pan et 
al., 2011). Inactivation of CRMP-1 was even described to cause lamellipodia retraction in 
chick DRG (Higurashi et al., 2012). This localization and effect of CRMPs, at least in 
filopodia, seems best explained by its actin binding or actin bundling activity. Yet the 
detailed molecular mechanisms remain obscure.  
v. Post-translational modification of CRMPs 
1. Phosphorylation 
        CRMPs are cytosolic phospho-proteins with extensive studies on its kinases and the 
corresponding phosphorylated residues. The physiological functions of the CRMP family 
protein in growth cones have been shown to be highly related to its phosphorylation.  
        For being a downstream effector of the repulsive cues, CRMP is phosphorylated by 
different kinases. CRMP-2 is phosphorylated at Theronine 555 by Rho kinase in response 
to lysophosphatic acid (Arimura et al., 2000). Downstream of Sema3A signaling, Fes/Fps 
phosphorylates CRMP-1, -2, and -4 (Fukata et al., 2002); CdK5 and GSK3-beta 
phosphorylate CRMP-2 at Serine 522 (priming phosphorylated site), Theronine 509, 
Threonine 514 and Serine 518 (Brown et al., 2004; Gu and Ihara, 2000; Uchida et al., 
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2005; Yoshimura et al., 2005). Dephosphorylation of CRMP-2 at Threonine 514 can be 
processed by protein phosphatase 1A and protein phosphoatase 2A (Cole et al., 2008; 
Zhu et al., 2010). Phosphorylation of CRMP-2 at Serine 522 has an essential role for 
regulating dendritic branch trajectories in the cerebral cortical neurons in vivo in mice 
(Yamashita et al., 2012). Tyrosine 32 of CRMP-2 is phosphorylated in response to 
Sema3A mediated activation of the tyrosine kinase Fyn (Yamashita et al., 2007). Fyn can 
also phosphorylate CRMP-1 at Y504, providing an isoform specific phosphorylation. The 
upstream signal for this phosphorylation on CRMP-1 remains unclear (Buel et al., 2010). 
Overall, it is generally believed that these phosphorylations would decrease CRMPs’ 
ability to bind tubulin dimers with consequences for microtubule disassembly resulting in 
growth cone collapse.  
        Phosphorylation of CRMP family protein can regulate neuronal morphology with 
molecules other than tubulin. As mentioned, CRMP-1 can bind to filamin. 
Phosphorylated CRMP-1 at Serine 522 increases its affinity with filamin. Therefore, in 
response to Sema3A, phosphorylated CRMP-1 might deprive filamin from crosslinking 
actin filaments in order to facilitate cytoskeletal remodeling (Nakamura et al., 2014). The 
effect of different phosphorylation of CRMP on its ability to directly bind to actin 
filaments is not clear. Kaibuchi and colleagues proposed that phosphorylation of CRMP-
2 at Threonine 555 (by Rho Kinase) or at Theronine 514/Serine 518/Serine 522 (by Cdk5 
and GSK3-beta) does not affect the protein binding to actin (Arimura et al., 2005).  
        Phosphorylation of CRMPs also has a role in non-neuronal cells. Perturbing 
phosphorylation of CRMPs causes abnormal phenotypes in a lung cancer cell line: 
alanine mutation on CRMP-2 substituting for Serine 522 increases the number of 
multinucleated cells in A549 NSCLC (Oliemuller et al., 2013). In immune cells, CRMP-2 
functions as a transducer for chemokine signaling. The chemokine CXCL12 induces Yes-
dependent Tyrosine 479 phosphorylation of CRMP2 and decreases GSK3-beta induced 
phosphorylation at Threonine 509/514, resulting in chemokine-mediated T-cell 
polarization and motility (Varrin-Doyer et al., 2009; Vincent et al., 2005). 
        With all the different phosphorylation sites on CRMPs, the cell might have 
established a hierarchical regulatory system to control CRMP function. For example, 
phosphorylation generated by GSK3-beta requires CDK5 to “prime” a phosphorylation at 
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Serine 522 (Cole et al., 2008). Another example can be found in the phosphorylation of 
CRMP-2 Tyrosine 479. Tyrosine 479 is not exposed on the protein surface. 
Dephosphorylation of CRMP-2 at Threonine509/514 might be essential to alter the 
overall charges in the vicinity of Tyrosine 479, and hence enhance the stability of 
phosphorylation at this residue in response to chemokine signal (Varrin-Doyer et al., 
2009).  
2. O-glycosylation 
       There is only one paper mentioned the glycosylation on CRMP-2. CRMP-2, in the 
synaptosomal cytosol, is O-glycosylated by a single beta-N-acetylglucosamine at 
serine/threonine (Cole and Hart, 2001). The authors also proposed the interrelationship of 
O-glycosylation and O-phosphorylation for regulating the function of CRMP-2 in 
synaptosomes: when CRMP-2 is O-glycosylated, the phosphorylation of CRMP-2 is 
blocked. As a consequence, CRMP-2, in its non-phosphorylated state, functions to 
promote growth cone formation.  
        Many actin binding proteins, such as vinculin, talin and synapsin (Cole and Hart, 
1999; Hagmann et al., 1992; Hart, 1997), are O-glycosylated, yet with little 
understanding about the related function. The glycosylation of other CRMPs in 
synamptosome, or the glycosylation of CRMPs in other tissue, has not yet been addressed. 
We do not know if different CRMPs or different isoforms represent distinct O-
glycosylation either. Deciphering the post-translational modifications and the upstream 
regulatory pathway of CRMPs would help understand how proteins were regulated 
spatially and temporarily. It will also help extend our understanding on the CRMP 
function.  A major challenge in the future will be to examine how all the various CRMP 
isoforms and their posttranslational modifications alter microtubule and actin 
organization in cells to promote or inhibit cell motility. 
vi. Sequence and the related function of the CRMPs 
        CRMPs have a core DHPase-like domain and a positively charged C-terminal region, 
which is highly susceptible to proteolysis (Deo et al. 2004). Domains and motifs in 
CRMP-1 were predicted through structure modeling and motif prediction (Shih et al., 
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2003). This chapter summarizes the truncation studies of CRMPs and the prediction from 
Shih et al. to provide an overall view of the sequence and the related function.  
1. Sequence for tubulin related function 
        The Kaibuchi group in 2002 provided the first evidence that CRMP family proteins 
physically interact with tubulin (Fukata et al., 2002). So far, two tubulin binding sites in 
human CRMP-2 were proposed: amino acids 323-381 (Fukata et al., 2002), and amino 
acids 480-509 (or, the 82 amino acids at the C-terminal) (Chae et al., 2009; Lin et al., 
2011). Even CRMP-5, the least conserved member in the CRMP family, uses similar 
residues (residues 475-522) for tubulin binding (Brot et al., 2010). Deletion and point 
mutation studies of human CRMP-2 further indicated that the region 480-509 contains a 
GAP activity for tubulin dimers. This 480-509 region is the essential region for tubulin 
polymerization by stimulating tubulin GTPase activity, while 323-381 region stimulates 
microtubule assembly in a tubulin GTPase activity-independent manner (Chae et al., 
2009).  
     CRMP itself might regulate its tubulin-binding ability in an auto-inhibitory manner. 
The first 300 amino acid of rat CRMP-4 was shown to have a counter-effect for tubulin 
polymerization. Deletion of this domain enhanced tubulin polymerization (Khazaei et al., 
2014). C-terminal truncated CRMP-1 (reside 1-490) alone failed to bind to tubulin, 
suggesting that the central region of CRMP is unlikely to serve as a binding site without 
conformational alteration (Lin et al., 2011). Similarly, an earlier study of the 
corresponding region in human CRMP-2 (amino acid 150-299) demonstrated that this is a 
self-inhibitory region that binds the tubulin-binding site (Chae et al., 2009). Structurally, 
residues 323-381 in both CRMP-1 (Deo et al., 2004) and CRMP-2 (Stenmark et al., 2007) 
are largely buried in the tetramer, indicating that tubulin binding to this region might 
require conformational change to release the protein from auto-inhibition. A more critical 
view of this result would be that CRMP-1 and CRMP-2 binding to tubulin is a complete 
artifact because the residues necessary for “tubulin binding” are buried deep within the 
molecule.    
2. Sequence for actin related function 
        CRMP-4 can bundle F-actin with the last 50 amino acids (amino acid 520-570) 
(Khazaei et al., 2014; Rosslenbroich et al., 2005). Consistently, this region was also 
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shown to contribute to filopodial length of the growth cones (Khazaei et al., 2014). Other 
than F-actin bundling activity, research also showed that CRMP-1 can interact with 
filamin A with residue 225-256, which might in turn indirectly regulate the amount of the 
bundled actin inside the cell (Nakamura et al., 2014). 
        Domain predictions done by Shih and colleagues reveals some interesting putative 
motifs that might contribute to actin-related functions (Shih et al., 2003). In their 
prediction, CRMP-1 contains two proline-rich extension signatures at residue 306-322 
and 503-528. Many cytoskeletal proteins contain proline-rich region, such as zyxin, 
Ena/VASP, vinculin, and Listeria monocytogenes ActA. The proline-rich domain serves 
as a binding site to interact with other cytoskeleton proteins. Listeria ActA and vinculin, 
for example, use the proline-rich domain to bind to the EVH1 domain of Ena/VASP 
protein. Ena/VASP can help link Listeria to the actin filaments through F-actin binding 
ability of Ena/VASP (Laurent et al., 1999; Niebuhr et al., 1997). It would be intriguing to 
know if CRMP-1, or CRMPs, can use its proline-rich extension signatures to connect to 
other cytoskeletal factors.  
3. Sequence for oligomerization and related function 
        CRMP family proteins form homotetramers and heterotetramers (Deo et al., 2004; 
Wang and Strittmatter, 1997). The N-terminal residues 8-134 and the core region residues 
281-435 (in CRMP-1) are sufficient for homo-oligomerization (Majava et al., 2008; 
Stenmark et al., 2007; Wang and Strittmatter, 1997). Studies have shown that CRMP-2 
and CRMP-3 can form heterotetramers (Wang and Strittmatter, 1997); CRMP-5 can 
interact with all the other CRMPs, yet with various affinity. For instance, CRMP-5 binds 
CRMP-2 better than CRMP-1 (Fukada et al., 2000; Ponnusamy and Lohkamp, 2013).  
        Through oligomerization, one CRMP variant might influence the function of a 
whole oligomer. For example, C-terminal deletion constructs of CRMP-2 (with C-
terminal 191 or 222 residues deleted) can have dominant-negative effects in cultured cells. 
In those truncations, the tubulin-binding site is deleted yet the oligomerization site is not. 
The truncated protein can bind and sequester the function of the endogenous full-length 
CRMP-2. Hence, the neuron transfected with those constructs display short or no axon 
(Inagaki et al., 2001). Note that this phenotype might also be a result from hetero-
interaction. How CRMPs regulate the formation of different hetero-oligomer and what 
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the physiological role of different hetero-oligomers are interesting questions that need to 
be explored. 
4. Calpain-cleavage site  
        Calpain is a calcium-dependent protease, which cleaves a large number of proteins 
including cytoskeletal elements such as spectrins (Siman et al., 1996) and regulatory 
protein CDK-5 (Smith et al., 2006). CRMPs, the S- CRMPs, are all substrates for calpain 
cleavage, resulting in products of 55 and 58 kDA (Bretin et al., 2006; Hou et al., 2006). 
However, the cleavage site is not clear. Even though clapain can digest all the CRMPs, 
the cleavage sites do not seem to be conserved among different CRMPs. The cleavage 
site for calpain for CRMP-2 has been mapped to the C-terminal between Serine 465 and 
Isolueucine 558 (Bretin et al., 2006). CRMP-4 is cut near the C-terminus (Bretin et al., 
2006; Chung et al., 2005; Deo et al., 2004; Kowara et al., 2005); whereas CRMP-3 is 
cleaved at the N-terminus (Hou et al., 2006). CRMP-1 was also detected as two protein 
products around 55 and 58 kDa in the mouse brain in a calpain-dependent manner (Jiang 
et al., 2007).  
        The physiological role of calpain cleavage is not fully understood. One result 
showed that cleaved CRMP-3 subsequently translocates to the nucleus and evokes 
neuronal death in response to excitotoxicity and cerebral ischemia (Hou et al., 2006). It is 
still unknown if it is also the case for other CRMPs. The function of calpain cleavage on 
CRMPs remains to be discovered.  
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CHAPTER 2: MATERIAL AND METHODS 
I.  Plasmids and Sequence 
i. Plasmids 
For recombinant protein expression in Escherichia coli (E. coli), we used different 
vectors that provide different affinity tags: pET30a (His-tag). pMAL (MBP-tag) and 
pGEX5-1 (GST-tag). Human CRMP-1, -2, -3, -5, DHPase and human EVL were and 
cloned into pET30a; human EVL was also cloned into pMAL; VVCA was cloned into 
pGEX5-1. His-tagged human CRMP-4 was purchased from Origene (Rockville, MD). 
His-tagged ActA was kindly provided by Mullins’ lab (University of California, San 
Francisco) (Akin and Mullins, 2008). GST-VCA was provided by Kovar lab (University 
of Chicago). For protein expression in MDCK II cells, human CRMP-1 was cloned into 
pLenti-III-HA with GFP-tag. For dominant negative EVL (EVL-DN), the tetramerization 
domain of the EVL is cloned into pLenti-III-HA. For shRNA-expressing plasmids, 
hybridized oligonucleotides were cloned into pLKO.1.  
ii. Sequence 
For knockdown approaches, the following target sequences were used: Scramble: 
plasmid 1864 (Addgene); CRMP-1 sh1: 5'- ACCTGGAAGATGGACTTATAA 
-3'; CRMP-1 sh2: 5'- CCAAGTCTACATGGCATATAA -3'; CRMP-1 sh3: 5'- 
GATGGATGAGCTAGGAATAAA -3'; p34 sh1: 5'-  TACGGGAGTTTCTTGGTAAAT 
-3'; p34 sh2: 5'- TACAATGTCTCTTTGCTATAT -3'; p34 sh3: 5'-
GCCTCTGTCTTTGAGAAATAT -3'; APR3 sh1: 5'- 
GTAGATGCCAGACTGAAATTA -3'; ARP3 sh2: 5'- 
AGAAATTGGACCTAGCATTTG -3'; ARP3 sh3: 5'- 
GTCGTCACAATCCAGTGTTTG -3'; EVL sh1: 5'- CAGCAGGTTGTGATCAATTAT 
-3'; EVL sh2: 5'- GCAGGGATTCAGCCGGATAAA -3'; EVL sh3: 5'- 
AGGAGGCCTCATGGAAGAAAT -3'; WAVE-2 sh1: 5'- 
TGGGCAGCCTGAGTAAATATG -3'; WAVE-2 sh2: 5'- 
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GGTCGACCGCCTACAAGTTAA -3'; WAVE-2 sh3: 5'- 
TCCAAATCGAGGGAATGTAAA -3'. 
 
II. Protein Purification 
i. Purification of CRMP-1 from brain cytosol  
1. Initial unbiased fractionation  
        All chromatographic media were purchased from GE Health Care. 150 grams of 
frozen bovine calf brain (Animal Technologies, Tyler, TX) was homogenized in two 
volumes of buffer B (20 mM Sodium Phosphate, pH7.5, 25 mM NaCl, 2 mM EGTA, 10 
mM beta-mercaptoethanol and 0.1 mM PMSF).  The homogenate was first centrifuged at 
15,000X g for 30 minutes. The pellet was discarded and the supernatant centrifuged at 
100,000 X g for 2 hours. The supernatant was applied to a 60 ml DE-52 column 
equilibrated in buffer A. The flow through, which contained the activity, was applied to a 
70 ml S HP column equilibrated in buffer A. The column was eluted with a 500 ml 
gradient to 400 mM NaCl in buffer A.  Active fractions were pooled and solid 
ammonium sulfate was added slowly to a final concentration of 1.25 M. Insoluble 
material was removed by centrifugation at 20,000X g for 30 minutes at 4oC.  The 
supernatant was applied to a 70 ml Phenyl HP column equilibrated in 1.25 M ammonium 
sulfate in buffer A. The column was eluted with a one liter gradient to buffer A.  Active 
fractions were concentrated in a centricon with a 100 kD nominal cutoff and the retentate 
applied to a Superdex 200 gel filtration column equilibrated in 20 mM MES, pH 6.5, 100 
mM NaCl.  Active fractions were pooled, diluted with an equal volume of water and 
applied to Mono S column equilibrated in 20 mM MES, pH 6.5, 20 mM NaCl.  The 
column was eluted with a 25 column volume gradient to 300 mM NaCl in the same 
buffer.   
2. Mass spectrometry 
        Gel slices were destained in 50% acetonitrile+25 mM AMBIC, crushed using a 
plastic pestle and dried.  The dried gel was suspended in 25 mM AMBIC and digested 
with MSG-Trypsin (G-Biosciences, St. Louis, MO) at a ratio of 1:10 – 1:50 using a CEM 
Discover Microwave Digestor (Mathews, SC) at 55˚ C and maximum power of 60 watts 
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for 15minutes. Digested peptides were extracted using 50% Acetonitrile + 5% formic 
acid twice and lyophilized. The digested peptides were dissolved in 5% acetonitrile + 
0.1% formic acid for LC/MS.  LC/MS was performed using a Thermo Dionex Ultimate 
RSLC3000 operating in nano mode at 300 microliters/min with a gradient from 0.1% 
formic acid to 100% acetonitrile + 0.1% formic acid in 120 minutes. The trap column 
used was a Thermo Acclaim PepMap 100 (100 µm x 2 cm) and the analytical column 
was a Thermo Acclaim PepMap RSLC (75 µm x 15 cm).  Xcalibur raw file was 
converted by Mascot Distiller into peaklists that were submitted to an in-house Mascot 
Server and searched against specific NCBI-NR protein databases. 
 (Experimental procedure of section II. i: Courtesy of William M. Brieher).  
ii. Recombinant protein purification 
        Rosetta E. coli cells (EMD Millipore) were used for expressing recombinant 
proteins. Recombinant proteins were induced at room temperature and then purified 
according to manufacture’s instructions (Qiagen, USA). Purification was undergoing 
native condition, except for ActA. In brief, the bacteria expressed His-tagged CRMP-1 
was pelleted and lysed with lysozyme in lysis buffer (150 mM NaCl and 50 mM Tris, pH 
8.0) in the presence of 2-mercaptoethanol and 0.2 mM PMSF. For His-tagged ActA, we 
used denaturing condition, in which 3 M guanidine hydrochloride was added to the lysis 
buffer. We applied the supernatant to Ni-NTA column. The column was then washed 
with lysis buffer and eluted with increasing concentrations of imidazole. The final eluted 
fraction was dialyzed against a different buffer according to the experimental need. Final 
elution of His-tagged ActA was dialyzed into 1 mM EGTA, 50 mM KCl, 1 mM MgCl2, 
10 mM Tris or Hepes, pH8.0). 
iii. Endogenous protein purification  
        Arp2/3 complex was purified from calf thymus as described (Welch et al., 1997). 
Filamin was purified from chicken as described previously (Shizuta et al., 1976). Actin 
was purified from rabbit muscle; pyrene actin was prepared as described (Bryan and 
Coluccio, 1985). 
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III.  Biochemical Assays 
i. Listeria preincubation assays 
1. Listeria 2-step preincubation assay 
        Listeria actin assembly reactions were performed in perfusion chambers as 
described previously (Brieher et al., 2004). Briefly, Listeria absorbed to glass coverslips 
in perfusion chambers were incubated for 5 minutes with brain cytosol, column fractions, 
or recombinant protein at concentrations listed in the main text (step 1, preincubation 
step). Chambers were washed three times with buffer A (1 mM EGTA, 50 mM KCl, 1 
mM MgCl2, 10 mM Tris, pH7.8). Chambers were then filled with a solution containing 
100 nM Arp2/3 complex and 2 M G-actin labeled with Oregon Green (10% labeled) 
(step 2, nucleation step). After 10 minutes, this solution was washed out of the chamber 
and actin cloud and comet tail assembly were imaged with a 20X (NA 0.7) objective 
attached to a 1,000 × 1,000 charge-coupled device camera (ORCA-ER; Hamamatsu 
Photonics) on a Zeiss AxioImager with the Colibri illumination system using Zeiss 
acquisition software (Carl Zeiss). 
2. Listeria 3-step preincubation assay 
        The 3-step preincubation assay is similar to the 2-step assay described in the 
previous paragraphs with an additional step (step 3. Elongation/nucleation step). After 
step 2 (initial nucleation step), the chambers were washed three times with buffer A and 
then provided with solution with 2 M G-actin. Different G-actin solutions was used in 
different steps in order to distinguish the actin built during each step.  
ii. Immunodepletion of CRMP-1 and rescue experiments 
        Polyclonal rabbit anti-CRMP antibodies were raised against purified recombinant 
human CRMP-1. The CRMP-1 antiserum itself was specific and sufficient for all western 
blotting procedures.  For immunodepletion experiments, however, the antibodies were 
affinity purified using recombinant CRMP-1 coupled to affi-10 according to the 
manufacturer’s instructions (Bio-Rad, USA). The affinity purified antibodies were 
coupled to affi-10 beads at a ratio of 1 mg of protein to 1 ml of beads.  For 
immunodepletion of CRMP-1 from brain cytosol, 100 l of affinity purified anti-CRMP-
1-antibody coated beads or beads coupled with non-immune rabbit IgG were added to 
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200 l of brain cytosol and incubated at 4oC for one hour with constant tumbling. Beads 
were then pelleted by centrifugation. The supernatant was diluted 1:3 into buffer A 
supplemented with 0.2 mM ATP and with additional 62.5 nM Arp2/3 complex and 2 M 
25% fluorophore-labeled actin. This mixture was applied to a perfusion chamber, 
containing L. monocytogenes, for 5 minutes at room temperature. In rescue experiments, 
recombinant CRMP was added to the same amount as endogenous CRMP-1 (0.01 
mg/mL), which was determined by western blot, into the perfusion chamber to 
preincubate with Listeria. Comet tail assembly was analyzed by fluorescence imaging 
using a 63× objective lens (NA 1.4) under a Hamamatsu camera described above. The 
number of Listeria with actin tail and actin tail length were quantified using Fiji software 
(Schindelin et al., 2012). Depletion of CRMP-1 was confirmed by western blotting. 
iii. In vitro actin assembly assays 
1. Pyrene actin polymerization assay 
        Actin polymerization was monitored by the increase in fluorescence of pyrenyl-actin 
with excitation at 365 nm and emission at 410 nm. The reaction contains 2.5 uM actin 
(25% pyrene-labeled) and different protein mixture in buffer B (1 mM EGTA, 50 mM 
KCl, 1 mM MgCl2, 10 mM imidazole, pH7.0) with 2 mM ATP. We used 25 nM or 50 
nM Arp2/3. The concentration of other proteins used was indicated in the figures.  
2. Actin assembly on the purified membrane  
        Actin assembly and immunofluorescence of purified rat liver membrane were 
proceeded as following: described before . In brief, the lyophilized rat liver membrane 
was resuspended in buffer A at 4 °C for 30 minutes. Potassium chloride was added into 
the buffer to a final concentration of 500 mM. The membranes were incubated in this 
high salt condition for 30 minutes on ice, then were centrifuged at 10,000 g for 30 
minutes. The pellet was reserved and resuspened in buffer with 2 mM ATP. To test actin 
polymerization on the salt-stripped membrane, 0.5 M fluorescently labeled actin, 1 M 
recombinant alpha-actininin-4 and 5 L preimmune serum were incubated with 
membrane and incubate for 10 minutes at room temp. In parallel, preimmune serum was 
replaced with 5 L purified anti-CRMP-1 antibodies. For immunofluorescence of 
membranes, homemade polyclonal alpha-actinin-4 antibodies and E-cadherin antibodies 
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(DECMA-1; sc-59778) (Santa Cruz Biotech) were used as primary antibodies followed 
with a secondary antibody conjugated with fluorophore (Life Technologies). 
iv. Filament branching assay 
        Pre-polymerized filaments were first prepared by incubating 2.5 M Alexa-Fluor 
647-labeled actin (10% labeled) in buffer B for 30 minutes at room temperature. These 
filaments were then diluted 10 fold into solutions containing 2.5 M Alexa-Fluor 647-
labeled G-actin with or without 0.6 M Arp2/3, 0.4 ActA, and/or 0.125 CRMP-1, 
for 10 minutes. The filaments from this reaction were then diluted 1:50 into Buffer B 
with 15 mM glucose, 20 μg/ml catalase, 100 μg/ml glucose oxidase, and 1 mM TROLOX, 
then immediately applied into the chambers which had been pre-coated with 40 g/mL 
filamin. Filaments were allowed to attach to the chamber for 10 minutes then detected by 
fluorescence imaging using a 63× objective lens as described above. 
v. F-actin co-sedimentation 
        Four sets of co-sedimentation experiments were conducted. Two sets used CRMP-1 
concentrations of 0.125 M, 0.25 M, 0.5M, 0.75M, and 2.5M. Two other sets 
used CRMP-1 concentrations of 0.75M, 1.25M, 2.5M, and 4M. Actin was 
provided at constant 2 M with various concentration of CRMP-1 in different tubes. 
Actin was polymerized at 4oC overnight in buffer B and 2mM ATP in the absence or 
presence of various concentrations of CRMP-1. The tubes were then centrifuged in a 
Beckman TLA 100 rotor at 350,000 × g (k factor, 8.1) for 20 min at 4 °C to separate 
supernatant and pellet fractions. The fractions were separated using SDS-PAGE. The gel 
was stained with coomassie blue and analyzed using Fiji software.  Curve fitting was 
done using OriginLab software. 
vi. Protein interaction assays 
1. ActA and CRMP-1 interaction 
        The affinity of ActA for CRMP-1 was determined using the approach described by 
Pollard (Pollard, 2010). Recombinant ActA was immobilized onto affi-10 gel (Bio-Rad, 
USA) according to manufacturer’s manual. Briefly, after the affi-10 gel was activated, 
recombinant ActA protein was added to the gel solution containing 50 mM KCl, 1 mM 
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MgCl2, and 10 mM Hepes, pH7.8. ActA was allowed to couple onto the gel overnight at 
4 °C. The final coupling density was 1.5 mg of ActA per ml of gel. The gel was blocked 
in casein solution for 30 minutes then washed with buffer A before use. The control gel 
was only coated in casein. 
        Twelve point five L of the ActA-coated gel was used to incubate with various 
concentration of CRMP-1 to final volume of 112.5 L. For control reactions, the blank 
gel was used. After an hour of incubation at 4 °C, the gel was pelleted using 
centrifugation. The supernatant was carefully separated from the gel, separated on SDS-
PAGE followed by western blotting using our custom polyclonal antisera (not affinity 
purified) against CRMP-1.  HRP-conjugated secondary antibodies (Bio-Rad, catalog 
number: 1706515) and chemiluminscence were used to visualize the amount of CRMP-1 
in the supernatants by exposing the blots to autoradiography film.  Multiple exposures 
were obtained to ensure the signals were in the linear range. The amount of CRMP-1 
bound to ActA was determined by subtracting the total amount of CRMP-1 in the control 
condition from the amount of CRMP-1 left in the supernatant. This approach permitted 
the estimation of binding affinity from the concentration of CRMP-1 required for half-
maximal binding to ActA beads. The results from 3 independent western blotting were 
analyzed using Fiji software and the curve was fitted using OriginLab software. 
2. CRMP-1 and EVL interaction 
        His-tagged CRMP-1 and MBP-tagged EVL were used for the interaction assay. 
Recombinant MBP-EVL was immobilized onto 0.5 micron carboxylated polystyrene 
beads (Bangs Laboratoris Inc., Fishers, Indiana) using two-step coupling of protein 
through EDC and Sulfo-NHS according to manufacturer’s manual (Thermo Fisher 
Scientific, Waltham, MA). Briefly, after the beads were activated, recombinant MBP-
EVL was added to the solution containing 500 mM NaCl, 100 mM MES, pH6.0. MBP-
EVL was allowed to couple onto the beads 30 minutes at room temperature. For the 
control condition, control gel was coated with MBP-tag peptide. The reaction was 
terminated with 2-mercaptoethanol. The final coupling density was 1 mg of protein per 
ml of beads.  
        Fifty L of the beads was used to incubate with 200 L of 1 mg/mL CRMP-1. After 
an hour of incubation at 4 °C, the gel was pelleted using centrifugation. The beads were 
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then fixed with formaldehyde for 20 minutes. After washing twice with PBS buffer, the 
gels were probed with anti-CRMP-1 antibodies follow with secondary antibody 
conjugated with fluorophore (Life Technologies). Centrifugation was used in between 
each step in order to remove unbound materials from the previous step.  
 
IV. Tissue Cultured Cells and Imaging 
i. Cell line  
        Madin-Darby Canine Kidney II cells (MDCK) and HEK 293 were used for the 
experiments. The cells were cultured at 37oC under 5% CO2 in Dulbecco's Modified 
Eagle's Medium with 5% FBS. MDCK cells were used to carry all the experiments; 
except for expressing Sema3A, HEK 293 cells were used. Transfection was carried using 
calcium phosphate precipitation. Western blotting was used to validate the knockdown 
efficiency. For western blotting, we used Bradford assay (Bio-Rad) to verify that the 
same amount of sample from different condition was provided for each lane. All the cells 
were plated on coverslips coated with collagen and analyzed within 96 hours after 
transfection.  
ii. Calcium switch assay 
        The cells were plated on collagen coated coverslip with a concentration that would 
allow the cells to reach confluency in 2 days. The calcium switch experiment were done 
on the 3rd day of the confluency. Confluent monolayers were first washed PBS with 2 
mM MgCl2, then were incubated in PBS with 2 mM MgCl2 and 4 mM EGTA for 30 
minutes in the tissue culture incubator. For cells to recover and reform cell-cell junction, 
the PBS buffer was removed and regular media with 5% FBS were added. Cells were 
fixed at different time point followed with immunostaining procedures in order to detect 
actin and E-cadherin signals. 
iii. Fixation and staining  
To probe the desired proteins and actin structures, various fixation procedure were used. 
For single spreading cells, formaldehyde fixation and TCA fixation were used. In 
formaldehyde fixation, the cells were fixed with 1% formaldehyde, permeabilized with 
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0.2% Triton X-100, and followed with immunostaining and phalloidin statining. For 
immunostaining, cells were probed with primary antibodies for one hour. After the 
primary antibodies, the cells were washed three times with PBS and then provided 
secondary antibodies conjugated with fluorophore. After proper wash to remove residual 
antibodies, phalloidin actin were added to staining F-actin. All the antibodies and 
phalloidin were diluted into PBS according to manufacturers’ manual. For TCA fixation, 
10% TCA were used. For detecting proteins in a monolayer, extraction and fixation 
procedures were adopted from Takenawa group (Yamazaki et al., 2007). The cells were 
first extracted in the presence of 2 M phalloidin. Next, primary antiboides were added 
prior to formaldehyde fixation. The fixation reaction was quenched with 50 mM Tris in 
the absence of detergent. Secondary antibodies conjugated with fluorophore were 
provided in the last step. For staining microtubule, methanol fixation was used. In brief, 
the cells were treated with -20oC methanol for 5 minutes. After 3 times of PBS washes, 
the cells were permeabilized with 0.1% Triton X-100 at room temperature for 30 minutes. 
Primary (anti-tubulin antibodies, Sigma) and secondary antibodies conjugated with 
fluorophore were provided afterwards. Fluorescence images were collected by 63x 
objective attached to a 1,000 × 1,000 charge-coupled device camera (ORCA-ER; 
Hamamatsu Photonics) on a Zeiss AsioImager with the Colibri illumination system under 
Zeiss acquisition software (Carl Zeiss). 
iv. Hanging drop adhesion assays 
        This assay was performed as described by Nelson group with some modifications 
(Ehrlich et al., 2002). In brief, cells were allowed to grow in a 10 cm dish for 2 days. 
Cells were trypsinized, centrifuged and resuspended in the media at 1.2 * 106 cells/ml. 
Twenty microliter drops of cell suspension were pipetted on the inside surface of 6 cm 
culture dish lids. At the bottom of the dish, 5 mL of media was provided to prevent 
evaporation. At each time point, two individual drops will be used and quantified. Each 
drop has five microliter of suspension spread directly on the glass slide, as the sample 
before trituration. Another five microliter of suspenstion was taken out from each drop, 
triturated ten times with a 20 microliter pipet before putting down on a glass slide. At 
least 3 random fields from each drop were photographed under Zeiss 20x objective. The 
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number of the cells and the size of clusters were determined. Note that same amount of 
cells were quantified in different conditions. 
v. Cell spreading experiment 
        For cell spreading experiment, freshly trypsinized MDCK II cells were plated on 
glass coverslips which were coated 0.5 g/mL Type I collagen (BD Bioscience). Cells 
were allowed to spread for 1 hour, then were fixed with 1% formaldehyde, permeabilized 
with 0.2% Triton X-100, and followed with immunostaining. For Arp2/3 inhibitor 
experiments, 100 nM CK-636 and 100 nM CK-548 (Nolen et al., 2009) were added into 
the medium during the 1 hour spreading time.  
vi. Wound healing experiment and live cell imaging 
        For detecting lamellipodia formation in response to wounding, a sharpened needle 
was used to wound a confluent MDCK II monolayer grew on collagen-coated coverslip. 
The monolayers were then allowed to recover in MEM with 5% FBS for one hour before 
immunostaining, or 5 minutes before collecting live cell images. Immunostaining of 
endogenous CRMP-1 was performed using the primary antibodies we generated, 
followed by secondary antibody conjugated with fluorophore (Life Technologies) at 
1:200 dilution in PBS for 1 hr. Alexa Fluor 647 Phalloidin (Life Technologies) was 
applied at the last step to stain for F-actin. Immunostaining of p34 subunit of Arp2/3 
complex was using the protocol described before (Yamazaki et al., 2007), with 
commercial polyclonal anti-rabbit antibody purchased from Millipore. Fluorescence 
images were collected under 63x objective as described before. Cell protrusive activity 
under wound healing condition were imaged at 24.5 oC. DIC images were acquired every 
5 seconds for a total of 5 minutes using 40× objective lens (NA 0.7) under a Hamamatsu 
camera described above.  
 
V. Data analysis 
        Data analysis of the results was carried out with Fiji software. Quantification results 
for the purified membrane and the tissue cultured cells, except live cell imagining, are 
mean ± s.d., from 3 repeats of the experiment. Quantifications for live cell imaging were 
analyzed with n=13. * p<0.05. ** p<0.01. For measuring actin intensity on purified 
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membrane, we manually outline the edge and divided the value with the size of the 
outline area. For quantifying high-intensity puncta on the purified membrane, the puncta 
were circled with radius of 0.5 m and the intensity were calculated. For measuring 
protein intensity at cell-cell contact or at the leading edge, we manually outlined the 
leading edge of protrusive structure. Average intensity value was the value of total 
intensity of the line drawn divided by the length of the line. To compare the amount of 
different proteins, the raw value was ratio to scramble or wildtype sample. For live cell 
image, tacking plug-in under Fiji was used to track the trajectory of the leading edge, in 
which the middle of the leading edge was followed.  
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CHAPTER 3: RESULTS  
I. CRMP-1 contributes to Listeria Actin Tail Formation 
i.  Identification of CRMP-1 as a new factor for Listeria actin tail formation  
        Previous research implied that there are uncharacterized factors in the cytosol that 
could help Listeria actin tail formation. We were interested in finding those factors; more 
specifically, we wanted to identify the factors that can enhance the initiation of the 
Listeria actin tail. To pursue this goal, we set up a two-step preincubation assay which 
allowed us to visualize and compare actin polymerization under different conditions (Fig. 
1 A). In this assay, we pre-coated Listeria in a perfusion chamber. Brain cytosol was later 
applied into the chamber followed by a buffer wash to remove any unbound materials. A 
new solution containing Arp2/3 and fluorescently labeled actin was later introduced into 
the chamber; actin cloud formation was scored by fluorescence imaging. Under this 
experimental design, we focused on screening the factors that are able to associate tightly 
with the Listeria surface, and have contribution to actin assembly.  We observed a greater 
fraction of Listeria preincubated with brain cytosol formed actin clouds than Listeria 
preincubated with buffer alone, confirming there are such desired factors in the brain 
cytosol. 
        In order to further purify those factors, we used conventional chromatography to 
fraction the cytosol. The activity of the individual fraction for enhancing actin cloud 
formation was then tested with the two-step preincubation assay described above. Only 
the active fractions were then being applied to the next column. After serial fractionation 
and activity test, the final active fraction contained two bands of approximately 65 
kilodaltons (Fig. 1 B). Mass spectrometry result indicates both of the bands are Collapsin 
Response Mediator Protein-1 (CRMP-1) (Fig. 1 C). 
ii.  CRMP-1 is essential for Listeria Actin Tail Formation 
        Since there has been no prior research demonstrating CRMP-1 as part of the actin 
cytoskeleton network, we first wanted to confirm that we had purified the right factor. 
We expressed and purified recombinant His-tagged human CRMP-1 in the E. coli (Fig. 2 
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A). The recombinant protein was then used in the same two-step preincubation assay in 
order to verify its ability to enhance actin assembly. The CRMP-1 preincubation 
condition showed more actin cloud formation at a fixed time point compared to the 
control (Fig. 2 B). When we changed the procedure and provide CRMP-1 in the solution 
with Arp2/3 (rather than preincubated CRMP-1 with the bacteria), we still detected 
longer actin tails compared to the condition without CRMP-1 (Fig. 3). Therefore, CRMP-
1 is a new factor that can enhance actin assembly on Listeria. Quantification 
demonstrated that CRMP-1 provides a dose-dependent effect on actin cloud formation 
(Fig. 2 C). Using an equal concentration of Arp2/3, 80% more Listeria formed a 
detectable actin cloud when preincubated with 0.5 M CRMP-1. 
        Next, we wanted to assess the importance of CRMP-1 for Listeria actin tail 
formation. I performed an immunodepletion assay using the rabbit polyclonal antibodies 
our lab generated and successfully depleted 50-70% of endogenous CRMP-1 (Fig. 4 A). 
CRMP-1 depleted cytosol resulted in fewer and shorter actin comet tails (Fig. 4 B and C). 
These defects can be rescued by preincubating the Listeria with the recombinant CRMP-
1.  CRMP-1 therefore has an important role for Listeria actin tail formation.  
        We noticed that while preincubation of CRMP-1 can fully rescue the number of 
bacteria with detectable actin clouds, this rescue procedure can only partially rescue the 
tail length. Listeria actin tail growth is a complex procedure involving in different actin-
binding proteins. This result might indicate that while Arp2/3 is essential for initiation of 
comet tail assembly, actin comet tail elongation might be independent of frequent Arp2/3 
mediated actin nucleation reactions.  Arp2/3 independent comet tail elongation has been 
seen before under certain experimental conditions (Brieher et al., 2004). Arp2/3 
independent comet tail elongation requires the preincubation of the bacteria with brain 
cytosol. After the preincubation step, Arp2/3 was then provided to the reaction in order to 
initiate comet tail assembly. Brieher and colleagues showed that this comet tail will 
continue grow as long as fascin, an actin bundling protein, was provided to the reaction. 
The growing of the tail at this stage is Arp2/3-independent.  They suspected there were 
factors bound to the bacterial surface that permit elongation of the tail in the presence of 
fascin. Yet we still do not know what those factors are. Brieher and colleagues tested if 
EVL or VASP alone accounted for the elongation activity. EVL is a known Listeria-
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binding and actin-binding protein that contributes to actin tail formation (Laurent et al., 
1999). Preincubating the Listeria with EVL or its related homolog alone cannot 
effectively support actin tail growth in the absence of Arp2/3 (Brieher et al., 2004). 
Neither can CRMP-1 or the mixture of CRMP-1 plus EVL (Fig. 5). It is possible that 
CRMP-1 somehow also contribute to the tail elongation in an Arp2/3 independent fashion. 
Adding back recombinant CRMP-1 cannot rescue the tail length is due to the activity of 
the recombinant CRMP-1 is not comparable with the endogenous CRMP-1. This 
possibility will be discussed further in the following paragraph.    
          We noticed that a higher amount of recombinant CRMP-1 was required to boost 
actin formation under defined conditions (Fig. 2 C) than in the rescue experiment (Fig. 4). 
Half maximal induction of actin cloud formation under defined conditions with CRMP-1 
and Arp2/3 alone required 100 g/ml of CRMP-1 while rescuing CRMP-1 depleted 
extracts only required 10 g/ml CRMP-1. These differences open the possibility that 
either post translational modifications or additional cytosolic factors work in conjunction 
with CRMP-1 to further activate it to stimulate Arp2/3-dependent actin nucleation. 
CRMP-1 antibodies might pull down not only CRMP-1 but also CRMP-1-associated 
proteins. Those associated proteins might contribute to Listeria actin tail formation as 
well. One data to support this idea is the observation that recombinant CRMP-1 displays 
a higher buoyant density after incubating with cytosol for one hour (Fig. 6). Another 
possibility would be that endogenous CRMP-1 interacts with other CRMP family 
proteins to form hetero-oligomers (Wang and Strittmatter, 1997), which might result in 
the formation of a more potent activator of the Arp2/3 complex. Therefore, adding back 
recombinant CRMP-1 alone could not fully compensate for the loss of other proteins, 
which leads to less efficient tail formation. In aggregate, the results demonstrated that 
CRMP-1 is a novel factor for Arp2/3-mediated Listeria actin cloud and comet tail 
formation.  
iii.  CRMP-1 and CRMP family proteins facilitate Arp2/3-dependent assembly 
        We want to know the underlying mechanism CRMP-1 uses in this Listeria system. 
The purification procedures we used to identify CRMP-1 implies that it binds to the 
Listeria surface. Researches have shown that ActA is the only protein contributed by 
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Listeria to the actin assembly reaction (Domann et al., 1992; Kocks et al., 1992; Kocks et 
al., 1995; Pistor et al., 1994; Smith et al., 1995). CRMP-1 is therefore likely to bind to 
ActA. I tested this possibility using recombinant ActA and recombinant CRMP-1. ActA-
coated beads were incubated with solutions containing various concentrations of CRMP-
1.  After an incubation period, the beads were pelleted, and the amount of CRMP-1 
remaining in solution was quantified by Western blotting. This method is a simple 
approach suggested by Pollard to obtain the dissociation constant for a protein-protein 
interaction (Pollard, 2010). Using this method, I found that CRMP-1 binds to ActA-
coated beads, with an affinity of 2.5 M (Fig. 7 A & B).  
        To test whether CRMP-1 enhances ActA function, we performed pyrene-actin 
polymerization assays. In this assay, I conjugated pyrene to actin at cysteine residue 374, 
a residue that is located at the interacting interface between two actin molecules in the 
filament. This pyrene compound is sensitive to the solution environment. When the 
pyrene dye is in a hydrophilic environment, which occurs when the actin is in its 
monomeric state, pyrene fluoresce is quenched. However, when the pyrene compound is 
buried inside the actin polymer (hydrophobic environment), the fluorescence is no longer 
quenched and the signal can be detected by a fluorometer. This is a classic approach for 
monitoring actin polymerization over time.  
        We did not detect any stimulation of actin assembly by CRMP-1 alone or CRMP-1 
in conjunction with ActA (Fig. 7 C). Nor could we detect direct activation of Arp2/3 by 
CRMP-1 alone (Fig. 7 D). CRMP-1 itself is therefore not a nucleator nor a classic NPF 
capable of activating Arp2/3 directly. CRMP-1, however, facilitated ActA-activated, 
Arp2/3-dependent polymerization in a dose-dependent manner (Fig. 7 F). Similar effects 
can be detected by other CRMP family members. I expressed recombinant CRMPs and 
DHPase (Figure 8A) and repeated the pyrene assay. The results showed that different 
CRMPs seem to be able to facilitate this reaction to different extents (Fig. 8 B-D). For 
example, CRMP-3 seemed to be the most potent for ActA-Arp2/3 reacrion (Figure 8C). 
We also detected a slight increase in the rate of ActA-Arp2/3 polymerization in the 
presence of increasing amounts of DHPase (Fig. 8 D). These results reveal that: 1) CRMP 
family proteins are new factors that contribute to Listeria actin comet tail assembly; 2) 
CRMP family proteins can bind ActA and enhance its ability to activate the Arp2/3 
34 
 
complex; 3) other CRMP family members can contribute to ActA-Arp2/3 dependent 
actin assembly but they might not be equally potent. The difference is possibly coming 
from the intrinsic sequence difference among different CRMPs. Further studies are 
required to verify how CRMP family members contribute differently to Arp2/3 mediated 
actin assembly. 
iv.  CRMP-1 increases Arp2/3-dependent branching 
        Arp2/3 produces branched actin filaments, yet not all Arp2/3 activators increase the 
density of filament branches (Goley and Welch, 2006; Wagner et al., 2013).  To 
determine whether CRMP-1 increases Arp2/3 dependent branching, I imaged single actin 
filaments to compare the density of filament branches in the presence of ActA and 
Arp2/3 alone to that in the presence of added CRMP-1.  Our results indicated a greater 
number of branches in the presence of CRMP-1 than in its absence (Fig. 9 A & B). Many 
factors that facilitate Arp2/3-dependent actin nucleation and branching are also able to 
bind to F-actin (Goley and Welch, 2006; Huang et al., 1997). Previous work has shown 
that CRMP-4, a member of the CRMP family proteins, can bind to F-actin 
(Rosslenbroich et al., 2005). We used cosedimentation to show that CRMP-1 can also 
bind F-actin with an apparent affinity of 0.7 M (Fig. 9 C). CRMP-1 is therefore an F-
actin binding protein that is capable of increasing Arp2/3 dependent actin nucleation and 
Arp2/3 dependent actin filament branching. 
 
II. Localization and Functional Study of CRMP-1 at Cadherin-Mediated Adherens 
Junction in MDCK Cells 
i. CRMP-1 locates at cadherin-mediated cell-cell contacts 
         To understand the potential role of CRMP-1 in regulating actin dynamics 
mammalian cells, we first detected the localization of CRMP-1 inside the mammalian 
cells. Our first goal is to see if CRMP-1 localizes to any actin related structures. We 
chose to use epithelial MDCK cell since it can form various kinds of actin-dependent 
structures. MDCK cells can form a structurally and functionally polarized monolayer 
which has actin filaments distributed at different locations: microvilli at the apical surface, 
cell-cell interactions at the lateral surface, and cell-substrate interaction at the basal 
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surface. Among them, research has been interested in understanding the mechanisms that 
drive the formation of cell-cell contacts, since cell-cell adhesion is an essential 
determinant in the development of the polarized epithelial sheets.  
        When we used the CRMP-1 antibodies to perform immunostaining in MDCK 
monolayers, we detected CRMP-1 at the cell boundary where two cells contact. The 
CRMP-1 signal overlaps with E-cadherin and actin signal at cell-cell contacts (Fig. 10 A). 
This localization of CRMP-1 can be observed in the monolayers of different ages: the 
young monolayer (the 1st day of reaching confluency), the mold monolayer (the 6th day) 
(Fig. 10 A) and the mid-age monolayer (2nd-3rd day of confluency) (Fig 10 B). Close 
inspection of CRMP-1, E-cadherin and actin signals along the cell-cell contact reveals 
that the majority of CRMP-1 signal overlaps with cadherin signals at cell-cell contacts 
(Fig. 10 B & C). Yet some area (~15-20%) contains CRMP-1 signal without cadherin 
signals, and vice versa (Fig. 10 C & D). In contrast, every spots that contain CRMP-1 
signal show actin signal (Fig. 10 C). Our result demonstrates that CRMP-1 not only 
localizes to cell-cell contact, but also highly associates with actin filaments at this 
location. 
ii. CRMP-1 is recruited to cell-cell contact at the early stage of the contact re-
formation 
        We wanted to decipher the role of CRMP-1 at this cellular localization. Since 
CRMP-1 has been shown to facilitate actin polymerization for the Listeria actin tail, we 
speculated CRMP-1 might undergoes a similar mechanism inside the cell.  In order to 
mediate the stabilization of newly formed contact, actin polymerization occurs at 
adherens junction once two cells contact each other (Vasioukhin et al., 2000). CRMP-1 
might have a role in facilitating actin assembly during this process. To test our hypothesis, 
we first need to know if CRMP-1 contributes to the initiation of cadherin contact zone 
extension.  We used a calcium switch assay to detect the distribution of CRMP-1 and E-
cadherin in response to the chelation of extracellular calcium in confluent monolayers of 
the MDCK cells.  Extensive cadherin-based cell-cell contacts were observed before 
chelating reagent was provided, with CRMP-1 signal locating at the adherens junction 
(Fig. 11 A, untreated).  In the presence of the chelating reagent EGTA, cell-cell contacts 
were destroyed as expected. Both cadherin and CRMP-1 signals were excluded from the 
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cellular peripheries (Fig. 11, 0 min).  Removal of the chelating reagent induced a rapid 
recruitment of CRMP-1 to cellular periphery where the two cells meet. While E-cadherin 
seemed to distribute to cell-cell contact simultaneously with CRMP-1, some contact 
zones showing CRMP-1 signal contained no E-cadherin signal (Fig. 11, 15 min, yellow 
arrowhead).  At 30 minutes after removal of chelating reagent, both CRMP-1 and E-
cadherin signals form a solid line along cell-cell contacts (Fig. 11, 30 min).  These results 
support our hypothesis that CRMP-1 might have a role at the initial stage of junction 
formation.  In addition, the early arrival of CRMP-1 at the new contacts implies that 
CRMP-1 might help the recruitment of cadherin to the junction, which will be discussed 
later.  
iii. Depletion of CRMP-1 reduces cadherin and F-actin amount at the apical 
junction 
        CRMP-1 can facilitate Arp2/3 dependent assembly of Listeria actin comet tails. To 
address if CRMP-1 is also a regulator for actin filament polymerization at cell-cell 
contacts, we examine the change of the amount of junctional actin in the presence or 
absence of endogenous CRMP-1. Our first approach was to use phalloidin staining to 
compare the amount of F-actin in wildtype and CRMP-1 knockdown MDCK monolayers. 
While using shRNA to deplete CRMP-1 amount inside the cells, we detected a 50% loss 
of F-actin at the apical region of the cell-cell contacts (Fig. 12 A & B).  Surprisingly, the 
amount of cortical actin (F-actin in the middle of the cell) at the same focal plan was 
greatly reduced as well.  Quantification of the result indicates that depletion of CRMP-1 
causes more than 80% loss of the cortical actin intensity at the apical surface (Fig. 12 C).  
CRMP-1 is therefore important for the global accumulation of F-actin inside the cell.  
This result suggests that CRMP-1 might modulate actin polymerization in the 
mammalian cells, as its role in Listeria monocytogenes actin tail. 
iv. Reduced stress fiber was detected in the CRMP-1 knockdown cells 
        The reduction in F-actin intensity after phalloidin-staining can also be detected at the 
basal surface. Wild-type MDCK cells form stress fibers that contribute to focal adhesion 
assembly that attach cells to the extracellular matrix. We detected a dramatic loss of 
stress fibers in the basal area of CRMP-1 knockdown cells (Fig. 13 A). While measuring 
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the actin intensity along the detectable fibers, more than half of the F-actin was lost when 
CRMP-1 is depleted (Fig. 13 B). While the width of the stress fibers did not seem to 
change much between scramble and CRMP-1-depleted cells (Fig. 13 C), other 
morphological characteristics seem to be different. Under fluorescence microscope, each 
individual stress fiber was displayed as a line composed by many higher-intensity dots. 
Those dots locate in close proximity to one another (Fig. 13 A, stars). However, those 
dots are more distant from one another in the CRMP-1 knockdown cells. The formation 
of the stress fiber in the MDCK cells is not yet clear if it is downstream of Arp2/3 
complex or downstream of other cellular nucleator, such as formin. Our initial data here 
showed that CRMP-1 might regulate basal actin accumulation and the integrity of stress 
fibers. Further study is required to test whether CRMP-1 has a direct effect on either 
Arp2/3 or formin mediated assembly of actin stress fibers. It is also possible that the 
changes in stress fibers we detected here are a downstream consequence of the massive 
changes in apical actin and cell-cell adhesion. The works from different groups have 
mentioned a significant crosstalk between apical cadherins and basal integrins. 
Purturbing the cytoskeleton of one location affects the cytoskeleton of the other locarion 
(Silvestre et al., 2009; Weber et al., 2011). 
v. CRMP-1 knockdown cells share similar many attributes with the Arp2/3 
knockdown MDCK cells 
        In Listeria actin comet tails, actin polymerization depends on the Arp2/3 complex. 
Inside the cell, Arp2/3 complex is also known to be the essential nucleator for the de 
novo actin polymerization. At cadherin mediated contacts, Arp2/3 activity is essential to 
efficiently generate actin filaments (Verma et al., 2004). We wondered if the global loss 
of actin in CRMP-1 knockdown cell can be explained by the change in Arp2/3 activity.  
We especially interested in the role of CRMP-1 at adherens junctions, since the 
mechanism of how and what are the regulatory components involved in this Arp2/3 
dependent process remain unclear.  To test the possibility that CRMP-1 and Arp2/3 
contribute to the same pathway, we generated different knockdown cell lines to detect if 
they share similar morphology. We made two kinds of Arp2/3 knockdown cell lines in 
parallel with CRMP-1 knockdown cells. We used shRNAs to target Arp3 or p34 subunits 
of the Arp2/3 complex individually, and stained for phalloidin in confluent monolayers 
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(Fig. 12 A). The efficiency of our knockdown approaches was verified by 
immunoblotting of cell extracts (Fig. 12 E). Similar to the results we observed in CRMP-
1 knockdown cells, both of the Arp2/3 knockdown cell lines showed loss of F-actin at the 
junction and in the cortical region. In addition, knockdown of these three different genes 
(CRMP-1, p34 and Arp3) leads to the same morphology: the apical surface area is 
enlarged (Fig. 12 D). Therefore, CRMP-1 and Arp2/3 might function in the same 
pathway to regulate actin polymerization in the MDCK cells and cell morphology. Note 
that other groups showed that the disturbing the function cortactin, a weak Arp2/3 
activator, also caused morphology change in MDCK cells. Those cortactin mutant cells 
displayed irregular outline; they lost the regular cubical shape of MDCK cell (Han et al., 
2014). Our CRMP-1 or Arp2/3 knockdown cells, however, remain the cobblestone shape, 
even though become flat in z-axis and enlarged in x-y axis. 
vi.  Arp2/3 might be less active under the CRMP-1-knockdown background 
        We wonder if there is a decrease in the Arp2/3 amount at the junction under CRMP-
1 depleted background. Our speculation came from the observation that 1) the junctional 
actin amount reduced in CRMP-1 knockdown cells; and 2) CRMP-1 knockdown cells 
showed similar phenotypes as Arp2/3 knockdowns. To answer this question, we 
quantified the intensity of Arp2/3 at the junctions. Immunostaining result showed that 
CRMP-1 knockdown indeed resulted in less accumulation of Arp2/3 at cell-cell contacts 
(Fig. 14 A). We also observed a decrease of alpha-actinin-4 at this cellular location after 
CRMP-1 is depleted (Fig. 14 B). Previous study from the lab showed that alpha-actinin-4, 
an actin-binding protein, has a critical role for Arp2/3-dependent actin assembly at the 
adherens junction. It is not yet known how alpha-actinin-4 is recruited to the junction. 
Our result here shows that CRMP-1 might contribute to Arp2/3 recruitment to the 
junction. The recruitment of alpha-actinin-4 to adherens junction might also be 
downstream of CRMP-1 function.  
        More interestingly, even though the amount of Arp2/3 and alpha-actinin-4 both 
reduced ~40% in the CRMP-1 knockdown cells (Fig. 14 A & B), they show different 
attributes while comparing their correlation with junctional actin amount (Fig. 14 C & D). 
Despite that junctional alpha-actinin-4 is reduced in CRMP-1 depleted cells, its 
correlation to the amount of junctional actin does not change compared to the scramble 
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condition (Fig. 14 D). In other words, the number of alpha-actinin-4 per actin remains the 
same in scramble and CRMP-1 depleted cells. This statistic result tell us that the loss of 
the junctional actin under CRMP-1 depleted condition was probably not due to less 
alpha-actinin-4 at the loci. In contrast, the correlation between Arp2/3 and junctional 
actin decreased almost half-fold when CRMP-1 is depleted (Fig. 14 C). The same amount 
of Arp2/3 in the scramble cells could generate more F-actin. In other words, in order to 
generate the same amount of junctional actin as wildtype, CRMP-1 knockdown cells 
would need to recruit more Arp2/3 complex. Arp2/3 complex might be less active 
without CRMP-1.  
vii. CRMP-1 highly associates with cadherin-enriched membrane fraction and 
contributes to de novo Arp2/3 polymerization in the purified liver membrane 
system 
        To better understand if CRMP-1 regulates the amount of F-actin through modulating 
actin polymerization in mammalian cells, we compared the efficiency of actin 
polymerization under different conditions using an in vitro membrane system. This 
membrane was obtained after various homogenizing-buffer washes followed with a 
serious centrifugation. This procedure allowed us to purify a membrane fraction that is 
enriched in the adherens junctional complex and is able to perform actin polymerization 
in an Arp2/3 dependent manner. It has been shown previously that actin polymerization 
initiates as 0.5-micron dots on this membrane at the loci where junctional proteins and 
Arp2/3 exist (Tang and Brieher, 2012). With this purified membrane, we can in vitro 
dissect the components involved in the actin assembly at cadherin-junctional-complex-
enriched foci by extracting different factors off the membrane with different solutions.  
This membrane system also allows us to biochemically reconstitute Arp2/3 dependent 
actin polymerization by adding back the extractable factors to restore actin assembly.  
        For example, high-salt treatment on the purified membrane attenuates actin 
polymerization because essential components for actin assembly were no longer remain 
on the membrane fraction. It has been shown that adding back alpha-actinin-4 could 
rescue Arp2/3-dependent polymerization on high-salt stripped membrane. Alpha-actinin-
4, a salt-extractable factor, is therefore required for Arp2/3-dependent actin assembly at 
the junctional complex foci (Tang and Brieher, 2012).  Unlike alpha-actininin-4, which 
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would be stripped off membrane at high-salt condition, a large portion of CRMP-1 
remains on the membrane fraction after high-salt treatment (Fig. 15 A).  In fact, CRMP-1 
could still associate with membrane fraction after sequential high-salt and detergent wash.  
This implies that CRMP-1 might strongly associate with adherens-complex to help 
maintain the integrity of junctional complex and/or to regulate the Arp2/3-dependent 
actin polymerization at cadherin adhesive sites.  
        To characterize the contribution of CRMP-1 on actin assembly on a molecular basis, 
we manipulated the activity of the membrane-bound CRMP-1 using CRMP-1 antibodies. 
These same antibodies have been used to perform immunodepletion experiments before 
(Fig. 4). We wished to use these antibodies to block the activity of the remaining CRMP-
1 on the high-salt stripped membrane. We provided CRMP-1 antibodies and alpha-
actinin-4 in the preincubation step. After the preincubation, we compared the efficiency 
of actin polymerization on the antibody-treated membrane (experimental condition, 
labeled as CRMP-1 Ab in Fig 15) with preimmune serum-treated membrane (control 
condition). Alpha-actinin-4 was added because alpha-actinin-4 is required to restore the 
assembly reaction on the stripped membrane. CRMP-1 antibodies did not affect the 
binding of alpha-actinin-4 to the membrane (Fig. 15 B); therefore we could rule out the 
possibility that any change in actin polymerization is due to the lack of alpha-actinin-4 on 
the membrane. The condition that the membrane was preincubated with CRMP-1 
antibodies (experimental condition), even in the presence of alpha-actinin-4, showed 
attenuation on the formation of Arp2/3-depedent actin polymerization (Fig. 15 C). Arp2/3 
dependent actin polymerization would result in high-intensity actin puncta on the 
membrane. The number of those puncta decreased in the experimental condition (Fig. 15 
D). Even though we sometimes observed the 0.5-micron foci on the membranes under the 
experimental condition, the actin intensity on those foci was relatively lower than the 
ones under the control condition (Fig. 15 D). Therefore, blocking CRMP-1 directly 
affects the efficiency of Arp2/3-dependent actin assembly on this in vitro purified 
membrane system. CRMP-1 is hence a new factor that directly regulates Arp2/3 
dependent polymerization at adherens junction.  
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viii. CRMP-1, rather than using VCA fragment of WAVE, works with EVL to 
activate Arp2/3 complex 
        Next, we examined through what mechanism CRMP-1 uses to modulate actin 
assembly on adherens junction. The molecular basis of CRMP-1 on actin assembly has 
been characterized in the Listeria system: CRMP-1 facilitates ActA-mediated Arp2/3 
polymerization. Listeria uses ActA protein as a NPF to recruit and activate the Arp2/3 
around the bacteria surface. Even though there is no known ActA homolog in the 
mammalian cells, VCA region of mammalian NPFs has been long considered 
functionally comparable to Listeria ActA (Zalevsky et al., 2001). ActA and VCA share 
many attributes, including binding and activating the Arp2/3 complex, and binding 
monomeric actin. At cadherin mediated junction, it has been shown that WAVE-2, a 
VCA-containing protein, serves as the essential activator for Arp2/3 complex (Verma et 
al., 2012). A small portion of WAVE-2 remains on our purified membrane after high-salt 
extraction (Fig. 15 A). It is possible that CRMP-1 collaborates WAVE-2 at cadherin-
mediated contacts to control Arp2/3 dependent polymerization. CRMP-1 might function 
with the known NPF in mammalian cell, just as the mechanism it uses in the Listeria 
system.  
        We hence test if CRMP-1 can facilitate Arp2/3 polymerization in the presence of 
VCA peptide, the essential region of WAVE to bind and activate Arp2/3 complex.  To 
our surprise, CRMP-1 can barely enhance VCA-Arp2/3 polymerization in pyrene actin 
assembly assay (Fig. 16 A). This result cannot explain why blocking CRMP-1 activity 
weakens de novo Arp2/3 polymerization on the purified membrane (Fig. 15 C & D).  
Neither can it explain why depletion of CRMP-1 inside the cell could cause such 
dramatic loss of F-actin at the junction, with a phenotype similar to Arp2/3-depleted cells 
(Fig. 12 A & B). This discrepancy suggested that even though there has been evidence 
showing WAVE-2 activates Arp2/3 at adherens junction, CRMP-1 might not go through 
WAVE-2 to contribute to actin assembly.  Instead, CRMP-1 might involve in a non-
canonical VCA pathway to build actin filaments at the junction.  
        We wonder if CRMP-1 works with other proteins that co-exist at the junction to 
regulate Arp2/3 activity. We mixed CRMP-1 with known junctional proteins, and tested 
the ability of the mixture to induce Arp2/3-depdent actin polymerization in pyrene actin 
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polymerization assay. While mixing CRMP-1 and EVL in the reaction, we successfully 
detected an enhancement on Arp2/3 dependent polymerization while even in the absence 
of VCA peptide (Fig. 16 B-D). Various biochemical studies have shown that VASP 
family proteins themselves can facilitate actin assembly due to its weak nucleation 
activity (Huttelmaier et al., 1999; Schirenbeck et al., 2006) and/or its intrinsic polymerase 
activity (Bilancia et al., 2014).  We did not detected an increase in polymerization rate by 
EVL alone in our condition. EVL and Arp2/3 alone, or CRMP-1 and EVL, does not seem 
to nucleates actin assembly either (Fig. 16 B). Actin polymerization only occurs when 
CRMP-1 and EVL are present in the reaction simultaneously with Arp2/3 complex. If the 
reaction started with EVL and Arp2/3, there is no induction in Arp2/3 dependent actin 
assembly. Yet if CRMP-1 was later added into the reaction, the rate of actin assembly 
suddenly increases (Fig. 16 C, orange curve). This combination (CRMP plus EVL) 
successfully induces Arp2/3-dependent polymerization in a dose-dependent manner (Fig. 
16 D). This reaction would be attenuated in the presence of Arp2/3 inhibitors (Fig. 16 E), 
further confirming that CRMP-1 and EVL induce actin assembly in an Arp2/3 dependent 
manner.  
        Previous studies shows that VASP family proteins can elongate actin filaments. 
CRMP-1 might be able to facilitate the actin polymerase activity of VASP family protein 
and hence boost the rate of actin polymerization. We tested this possibility by elongating 
the actin filaments in the presence of EVL, then adding CRMP-1 into the reaction. The 
rate of actin polymerization was recorded using the same pyrenyl actin polymerization 
assays. Our results showed that EVL alone can slightly increase the rate of actin 
polymerization in a dose-dependent manner. Adding CRMP-1 into the reaction can 
significantly increase the rate in pyrenyl assays, implying the positive role of CRMP-1 in 
facilitating EVL-mediated filament elongation (Fig. 16 F & G). Similar effect can be 
detected using the EVH2 domain, the actin binding domain, of EVL, but not with EVH1 
domain (Fig. 16 H). The other two VASP family proteins, VASP (Fig. 16 I) and Mena-
EVH2 (Fig. 16 J), can provide the similar trace in the presence of CRMP-1, indicating 
CRMP-1 can generously enhance the elongation rate of the three VASP family proteins.   
        In vitro binding assay demonstrates the direct interaction between EVL and CRMP-
1. CRMP-1 interacts strongly with beads coated with MBP-EVL, but not with MBP-
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peptide alone (control) (Fig. 16 K), with a binding affinity at 2 m (Fig. 16 L). CRMP-1 
seems to be specifically binding to the EVH2 domain of EVL (Fig. 16 M), which is 
consistent with our kinetic observation that CRMP-1 can boost actin polymerization in 
the presence of EVH2 domain, yet not EVH1 domain (Fig. 16 H). Therefore, CRMP-1, 
through binding with EVL, can facilitate EVL or VASP mediated actin polymerization. 
The two protein complex can also function as a novel Arp2/3 activator.  
ix.  EVL and CRMP localize to cadherin mediated junction and mediate 
junctional actin assembly 
        The discovery of CRMP-1 and EVL as Arp2/3 activators provide a way to explain 
our in vitro membrane results (Fig. 15) and the phenotypes of CRMP-1 knockdown cells 
(Fig. 12). CRMP-1 can directly affect actin polymerization by modulating Arp2/3 activity. 
Even though there are profound researches on Ena/VASP family protein showing that the 
recruitment of this family protein to cadherin-mediated cell-cell contact is important 
during junctional formation (Oldenburg et al., 2015; Vasioukhin et al., 2000), no research 
address the role of the homolog, EVL, as an Arp2/3 activator for this cellular process. We 
want to confirm the localization of EVL at cell-cell contacts in MDCK cells. Using the 
EVL antibodies we generated, we successfully detected EVL on adherens junctions of a 
confluent monolayers of MDCK cell (Fig. 17 A).  
        We next wanted to know if CRMP-1 and EVL localize to sites of Arp2/3-dependent 
actin assembly at the junction. Actin assembly at the apical junction of a confluent 
monolayer can be monitored using latrunculin treatment. Latrunculin is an actin 
monomer sequester. In the presence of laturncuin, the majority of the actin filaments 
would be depolymerized. A pool of stable actin, or the latrunculin-resistant puncta, 
remains along cell-cell contacts at the apical surface. Those latrunculin-resistant puncta 
have been shown to be the sites that contains Arp2/3 complex. Those puncta can also 
perform Arp2/3 dependent actin polymerization after the removal of latrunculin (Tang 
and Brieher, 2012). We probed CRMP-1 and EVL after latrunculin treatment in order to 
know whether CRMP-1 and EVL locate to those puncta where de novo Arp2/3 
polymerization takes place (Fig. 17 B). Our immunostaining results revealed that while 
the majority of F-actin at cell-cell contact disappeared after laturnculin treatment, there 
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were remaining actin along the cell-cell contacts in puncta shape. CRMP-1 and EVL 
signals indeed overlaped with those puncta.  
        CRMP-1 and EVL have to be present simultaneously to activate Arp2/3 in pure 
solution (Fig. 16 B). If CRMP-1 and EVL share this pathway inside the cell, then the 
removal of either one of them should abrogate the activation of Arp2/3 complex and 
reduce the formation of actin filaments. We knew that depletion of CRMP-1 alone caused 
loss of junctional actin, to an extend that is as severe as the Arp2/3 depleted cells. We 
then test if depletion of EVL alone would generate the same result. In a paralleled 
experiment, we depleted CRMP-1 or EVL individually inside MDCK cells and compared 
their phenotypes with the control cells transfected with scramble shRNAs. Consistent 
with the results we obtained earlier, CRMP-1 knockdown cells have reduced actin 
amount inside the cell. EVL knockdown cells obtained the same phenotype as CRMP-1 
knockdown cells (Fig. 17 C). In fact, perturbing EVL function by expressing dominant-
negative EVL (EVL-DN) can also reduce F-actin at the junction (Fig. 18). These results 
support our in vitro kinetic result: CRMP-1 and EVL has to present simultaneously in 
order to activate Arp2/3-dependent actin polymerization (Fig. 16). The number of actin 
per cadherin decreased when CRMP-1 or EVL was perturbed, indicating those two 
proteins contribute to the accumulation of actin amount at this loci (Fig. 17 D).  
        Interestingly, using immunostaining, we observed the loss of E-cadherin intensity in 
the knockdown cells. Arp2/3 activity is necessary for efficient formation of E-cadherin 
adhesive contacts (Yap, 2004). Actin polymerization at cadherin-mediated cell-cell 
contacts has been thought to stabilize the clustered cadherin receptors. Loss of cadherin at 
the junction might simply due to the loss of actin assembly in CRMP-1 or EVL depleted 
cells. Another possible explanation is that CRMP-1 can mediate cadherin clustering on 
the membrane. We detected CRMP-1 locates early to the cell-cell contacts (Fig. 11). 
CRMP-1 is also highly associated on the membrane (Fig. 15 A). CRMP-1 might serve as 
an adaptor protein to recruit cadherin molecules.  Moreover, we also detected a loss of 
the EVL intensity at the junction reduced in the CRMP-1 depleted cells (Fig. 17 D). In 
vitro result showed that EVL is easier to be extracted off the purified membrane after 
high-salt treatment compared to CRMP-1 (Fig 15 A). Since CRMP-1 and EVL directly 
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interact with each other (Fig. 17 K & L), CRMP-1 might be a receptor for EVL to be 
recruited cadherin-mediated cell-cell junction. This hypothesis needs to be further tested. 
 
x. Depletion of CRMP-1 or EVL decrease cell-cell attachment and reduces the 
rate of junction formation 
        Reduced actin and cadherin signal might result in biological defects. Misregulation 
of the proteins involved in cell-cell contact formation could cause pathological results, 
such as cancer. Even though the role of cadherin-mediated adherens junction in cancer 
biology is complex, it has been generally accepted that reduced E-cadherin and the 
sequentially impaired adherens junction favors the epithelia-mesenchymal transition at 
least in some cancers (Berx and van Roy, 2009). Emerging evidence showing the 
relationship of actin CRMP-1 or Ena/VASP proteins on cancer invasion (Ali et al., 2015). 
In fact, CRMP-1 has been referred to as cancer suppresser gene by different groups (Shih 
et al., 2001; Steeg, 2001). Our CRMP-1 knockdown cells showed reduced cadherin and 
actin at the junction might explain why CRMP-1 can suppress tumor progression.  
        We wanted to confirm that CRMP-1 knockdown indeed repeals the strength of cell-
cell adhesion, we used hanging drop experiments so that we can monitor cell clustering 
without the influence of focal adhesion. We also combine the experiment with trituration 
approach to test the resistance of the cell aggregates to a shearing force. At the beginning 
of the hanging drop experiment, both control cells and CRMP-1 knockdown cells were 
present as single cells or clusters of fewer than ten cells (Fig. 19, 0 hour). In control 
experiment, the number of cells in large clusters (more than 50 cells) covers 30% of total 
cells after 2 hours, and to almost 60% at 3-hour time point. In the contrarily, the majority 
of the cells remains as small clusters in CRMP-1 depleted condition even at 3-hour time 
point. After 4 hours, 70% of the cells are in large clusters in CRMP-1 depleted condition, 
while the control condition had already reached 98%. CRMP-1 depleted cells represented 
a slower rate on the formation of cell-cell contact. 
        Control cells showed better resistance to trituration than CRMP-1 depleted cells. 
Before trituration, the control cells at 3 hour and the CRMP-1 depleted cells at 4 hour 
shares similar cluster profile: 60-70% of the cells are in large clusters (more than 50 
cells); around 25% of the cells are in middle clusters (11-50 cells). After trituration, those 
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large clusters were all broken down to smaller size in CRMP-1 depleted cells, while 
around 50% of the control cells remains in large clusters. In agreement with our hang-
drop result, we noticed that the cells in the CRMP-1 knockdown monolayer are easier to 
be washed apart from each other (Fig. 20). These results showing that CRMP-1 depleted 
cells form slower and weaker cell-cell adhesion than the control cells, probably resulting 
from fewer F-actin at cell-cell contact (Fig. 12). 
 
III. Localization and Functional Study of CRMP-1 in Lamellipodia 
i. CRMP-1 locates to the leading edge of protrusive structures in MDCK cell 
        Our study on the confluent MDCK monolayers reveals the role of CRMP-1 for 
Arp2/3-dependent actin polymerization at E-cadherin-mediated cell-cell contacts 
(Chapter 3, II). When we used immunostaining to probe CRMP-1 in non-confluent 
MDCK cells, we detect CRMP-1 signal at the leading edge of the lamellipodia, an Arp2/3 
dependent structure (Fig. 21 A & B). It has been believed that when MDCK cells are 
plated at low confluency, they make protrusions that would facilitate the formation of 
cell-cell contacts (Ehrlich et al., 2002; Yamazaki et al., 2007). When we performed 
spreading assay to induce MDCK cells to form protrusions, both the endogenous CRMP-
1 and exogenous GFP-CRMP-1 colocalize with F-actin at the edge of the protrusive 
structures (Fig. 21 A & B), implying that CRMP-1 might contribute to actin assembly at 
this cellular location. Note that when we used TCA fixation to probe DHPase, a highly 
identical protein to the CRMP family, we observed that DHPase signal slightly enhanced 
at the leading edge of a single spreading cell (Fig. 21 C). Since the primary sequence of 
the CRMP family proteins are highly identical to the DHPase’s, the whole CRMP family 
might share this same cellular localization. In addition, the DHPase-like domain in 
CRMP-1, or other CRMPs, might be essential for the recruitment of CRMP-1 (CRMPs) 
to the lamellipodia. These hypotheses need to be tested in the future.  
ii. CRMP-1 is essential for cell spreading in an Arp2/3-dependent manner 
        To determine if CRMP-1-dependent protrusion is necessary for cell spreading, we 
compared the rate of cell spreading in CRMP-1 knockdown cells to the scramble 
condition. While 70% of the cells transfected with a scrambled shRNA extended 
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protrusions and spread on collagen within one hour, only 20% of the CRMP-1-depleted 
cells spread. The CRMP-1 depleted cells that did spread failed to make protrusion with 
classic characteristics of lamellipodia: a smooth edge with an enriched actin band at the 
leading edge. Depletion of CRMP-1 caused a loss of F-actin signal inside the cells: 
CRMP-1 knockdown cells does not have an enriched F-actin band at the edge of the 
protrusive structure. Comparing to the scramble cells, the intensive F-actin signal in the 
middle of the cell body is absent as well. In contrast, overexpression of GFP-CRMP-1 
increased the percentage of spreading with increase in F-actin signal at the front edge of 
the protrusions (Fig. 22 B) and throughout the whole cell (Fig. 22. A). These spreading 
results demonstrate that there is a positive correlation between the amount of CRMP-1 
and the amount of F-actin inside the cell. 
        Since the formation of F-actin at this cellular location is Arp2/3 dependent, and 
since CRMP-1 modulate Arp2/3 activity in the Listeria actin tail (Chapter 3.I) and at 
adherens junction (Chapter 3.II), we wanted to know if CRMP-1 and Arp2/3 involve in 
the same pathway to control lamellipodia formation. Previous results have shown that 
Arp2/3 activity is not required for fibroblasts to spread on fibronectin (Suraneni et al., 
2012). We do not know if this result can be applied to epithelial MDCK cell spreading. 
To test if Arp2/3 is necessary for epithelial cells to spread on substrate, we first inhibited 
Arp2/3 activity using small molecules (Nolen et al., 2009). Addition of 100 nm of Arp2/3 
inhibitors blocked cell spreading (Fig. 22). While using shRNAs to deplete either the p34 
subunit or the Arp3 subunit of the Arp2/3 complex, the percentage of cell spreading 
reduced ~70%-80%, as the result we observed from CRMP-1 depleted cells (Fig. 22 B).  
Thus, spreading of MDCK cells on collagen is an Arp2/3 dependent process that requires 
CRMP-1. 
iii. CRMP-1 contributes to F-actin accumulation at the leading edge of 
lamellipodia of a wounded cell 
        To test if the observations in spreading assay (Fig. 22) reveal the ability of the cells 
to form protrusions, we investigated the effect of perturbing CRMP-1 for making 
protrusions in response to the wound. Epithelial cells can close wounds by extending 
protrusive lamellipodia into the open area (Fenteany et al., 2000). Those lamellipodia are 
characterized by a band of concentrated F-actin at the leading edge (Fig. 23 A, no 
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inhibitors’ condition). We confirmed that this lamellipodia is indeed Arp2/3-dependent, 
since Arp2/3 inhibitors abolish its formation after wounding (Fig. 23C). 
        Next, we want to decipher if manipulating the amount of CRMP-1 inside the cell 
would affect the amount of F-actin at the leading edge. We depleted CRMP-1 inside the 
cell and wounded the cell on the 2nd day of confluency. The cells were allowed to recover 
for one hour after the wounding procedure. We stained for Arp2/3 complex with the 
antibody against p34 subunit of the Arp2/3 complex. We also used phalloidin to stain for 
stable F-actin. Depleting cells of CRMP-1 decreased both the amount of F-actin and the 
amount of Arp2/3 at the leading edge (Fig. 23 B & C).  In contrast, over-expressing 
CRMP-1 induced a greater fraction of cells to form lamellipodia. The protrusions in the 
CRMP-1-overexpressing background were enriched in F-actin and Arp2/3 relative to 
control cells (Fig. 23 C).  Note that CRMP-1-depleted cells made smaller protrusions 
compared to the scramble cells; CRMP-1-overexpression cells made bigger protrusions. 
Those results were consistent with our observation in the single spreading cell (Fig. 22). 
Hence, CRMP-1 contributes to the formation of Arp2/3-dependent protrusions during 
single-cell and confluent-cell stages. 
iv. No obvious change in microtubule organization was detected in CRMP-1-
depleted or –overexpressing cells  
          Interactions between the various CRMP family members and the cytoskeletons are 
complicated.  CRMP-2 binds to tubulin dimers to accelerate microtubule assembly while 
CRMP-4 has been shown to bundle actin filaments (Fukata et al., 2002; Khazaei et al., 
2014).  We wonder if manipulating CRMP-1 amount in the MDCK cell would alter the 
microtubule organization inside the cell. In other words, the effect of CRMP-1on 
lamellipodia formation (Fig. 22 and Fig. 23 B & C) might be the downstream effect of 
CRMP-microtubule pathway, since microtubule cytoskeleton also has a role in cell 
protrusions (Ballestrem et al., 2000; Wadsworth, 1999; Waterman-Storer and Salmon, 
1997; Wittmann and Waterman-Storer, 2001). 
        To investigate microtubule structures in response to our experimental conditions, we 
performed microtubule staining in the wounded monolayers. Our preliminary data shows 
that we did not see an obvious, gross alteration in microtubule organization among the 
three different genetic backgrounds: scramble cells, CRMP-1-depleted and CRMP-1-
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overexpressing cells (Fig. 24). Therefore, while genetically down- or up- regulation of 
the CRMP-1 provides a dramatic change in actin cytoskeleton, its effect on microtubule 
is minor or maybe neglectable. Note that our immunostaining results, which were 
obtained from fixed samples, could not address if there were changes in microtubule 
dynamics when we manipulated CRMP-1 amount inside the cell. Further study needs to 
be done to answer this question. 
v. Semaphorin 3A does not attenuate the formation of the protrusive structures 
in MDCK cells 
        There are profound researches on CRMP family proteins and Sema3A signaling in 
neuronal cells (see Chapter 1.V). Yet role of Sema3A in epithelial cell morphology or in 
regulating actin cytoskeleton remain obscure. MDCK cells express Sema3A receptor, 
Plexin (William M. Brieher, private conversations). We would like to test the possibility 
whether the spreading phenotype or the formation of the protrusive structures in the 
MDCK cells is Semaphorin-dependent.  
        We expressed exogenous Sema3A in HEK 293 cells. In control cells, we transfected 
empty vectors. The supernatant from these two conditions were collected and applied to 
MDCK cells under different experimental setups: freshly trypsinized MDCK cell 
undergoing spreading on collagen, or wounded MDCK cells undergoing recovery (Fig. 
III.5 A). In neuronal cells, Sema3A is a repulsive cue. CRMP family proteins contribute 
to growth cone collapse as a downstream effector for Sema3A signaling. If Sema3A also 
functions as a repulsive cue for the epithelial cells, then we should detect a defect of 
forming protrusive structures in the Sema3A-treated conditions. If the change in cell 
morphology after Sema-3A treatment phenocopies either CRMP-1 knockdown or 
CRMP-1 overexpressing cells, it would reveal the possibility that CRMP-1 works 
downstream of Sema3A in regulating epithelial cell morphology. Qualitative results 
showed that no significant change in the formation of protrusions in either experimental 
setup. Single cells could still spread and form protrusive structures (Fig. 25 B). In 
wounded monolayer, Sema3A-treated condition did not abrogate the lamellipodia 
formation at the wounded edge (Fig. 25 C). These preliminary results could not verify 
what role Sema3A has in epithelial MDCK cells, nor can it help distinguish if CRMP-1 
works downstream of Sema3A signaling in this cell type. We did not know the amount of 
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Sema3A was expressed by HEK 293 cells in this data set, either. More experiments need 
to be done in order to determine the contribution of Sema3A in MDCK cells. 
vi. CRMP-1 contributes to the stability of the protrusive edge 
        To better understand the role of CRMP-1 in Arp2/3 dependent cell protrusion, we 
acquired 5-minutes time-lapse movies of the leading edges after wounding (Fig. 26). We 
compared the behavior of leading edges between control cells and the cells depleted or 
over-expressing CRMP-1. Behavior of the leading edge was quantified by analyzing 
kymographs drawn from the time-lapse sequences (Fig. 26 A & B).  Depletion of CRMP-
1 had little effect on the average rate of lamellipodial advance compared to wild-type 
cells.  Leading edges of control cells and cells depleted of CRMP-1 both advanced at an 
average rate less than 0.2 microns/minute (Fig. 26 C).  However details within the 
kymographs showed that leading edges of CRMP-1 depleted cells were unstable and 
retracted frequently.  While CRMP-1 depleted cells might occasionally advance rapidly, 
this movement was offset by frequent, fast retractions of the leading edge.  In contrast, 
cells over-expressing CRMP-1 extended protrusions at a faster average rate of 0.87 
microns/minute.  In addition, leading edges of CRMP-1 over-expressing cells were stable 
and rarely retracted. Cortactin is another factor that is already known to facilitate Arp2/3 
dependent actin nucleation (Weaver et al., 2001).  Perturbing cortactin function has the 
same effect on lamellipodia dynamics as depleting CRMP-1 (Bryce et al., 2005).  The 
results then are consistent with the hypothesis that CRMP-1 promotes the assembly and 
stability of Arp2/3 dependent lamellipodia. 
 
vii. CRMP-1 contributes to the directionality in wounded monolayers 
        We next asked if CRMP-1 dependent changes in F-actin content altered cell 
migration. We pursued this question by comparing cell migration behavior during the 60 
minute following wounding as a function of CRMP-1 (Fig. 27 A). The three different 
cells (Scramble; CRMP-1 knockdown and CRMP-1-overexpressing cells) display distinct 
migratory characteristics. Control cells moved into the wound slowly yet maintained their 
directionality. In contrast, protrusions in CRMP-1-depleted cells advanced more rapidly 
yet lost directionality (Fig. 27 B & C). The movement of the leading edge of CRMP-1-
51 
 
overexpressing cells maintained their directionality while migrating faster (Fig. 27 C). 
Therefore, CRMP-1 not only controls the amount of F-actin in lamellipodia to produce a 
persistently advancing leading edge but also controls the directionality of cell migration.   
        In two-dimensional migration, such as our wound healing experiment, the 
movement of the cell sheet is considered to be the combination of exploration of new 
space, the initiation of substrate adhesion, the influence from the contraction force inside 
a cell, and the coordination of cell-cell adhesion with the adjacent cell. In both CRMP-1 
depleted and CRMP-1 overexpressed cells, an increased migration rate of the leading 
edge were detected during wound healing process. This result revealed that tuning the 
amount of CRMP-1 inside cell would affect the balance among the criteria listed above. 
Our current work showed the novel role of CRMP in regulating Arp2/3 related actin 
structures, especially in lamellipodia formation. Yet it did not rule out that CRMP-1 
might also have a role in other actin structures, which are dependent or independent of 
Arp2/3 complex. For instance, CRMP-1 might regulate the strength of focal adhesion 
(Kawahara et al., 2013) or cell-cell adhesion, on which cell migration is interdependent.  
        CRMP-1 might also function upstream of myosin to regulate cell migration. CRMP-
2, one of the CRMP family proteins, has been shown to have an inhibitory role for 
ROCKII, which indirectly regulates myosin activity and cell migration (Yoneda et al., 
2012).  Our result is not able to elucidate precisely why increase and decrease CRMP-1 
amount would trigger faster cell migration in wound healing experiment. Yet similar 
result can be found on CRMP-2 studies. Cell migration of SW620 cells was reduced 
while cells were transfected with one of the isoform of CRMP-2 (Yoneda et al., 2012).  
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CHAPTER 4: DISCUSSION 
        Previous researches imply the unknown factors remain to be discovered for Listeria 
actin tail formation (Brieher et al., 2004; Welch et al., 1997). We followed the protocol 
described by Brieher and colleagues (Brieher et al., 2004), and successfully identified 
CRMP-1 is such a factor that facilitates Arp2/3-dependent actin assembly on Listeria (Fig. 
1 & 2). In vitro biochemical assays revealed the molecular mechanism of which CRMP-1 
used to enhance Arp2/3 activity. CRMP-1 works with Listeria ActA and enhances ActA-
mediated Arp2/3 polymerization. We verified that CRMP-1 can interact with ActA (Fig. 
4). In other words, ActA might very likely to be the receptor on Listeria surface that 
recruits CRMP-1. This explains why CRMP-1 was able to be identified from brain 
cytosol by our 2-step preincubation assay (Fig. 1). Inside the cell, Ena/VASP family 
proteins are also able to bind to ActA. It has been known that the proline-rich domain of 
ActA is the ligand for EVH1 domain of Ena/VASP family (Laurent et al., 1999; Niebuhr 
et al., 1997). We have not yet dissect which domain CRMP-1 uses to bind to ActA. The 
ActA binding sequence for CRMP-1 also remains unverified as well. Now we show 
CRMP-1 and EVL, an Ena/VASP family protein, can activate Arp2/3 complex in the 
absence of the known NPF (Fig. 16). It would be interesting to know if the CRMP-1 
binding site on ActA is in close proximity of the EVL binding site. Since CRMP-1 and 
EVL interact with each other (Fig. 16), recruitment of either one of them should 
sequentially locate the other one to the Listeria surface. Under this condition, Arp2/3 
complex can be activated on the Listeria surface through two mechanism: Listeria ActA, 
and CRMP-1+EVL. 
        Our discovery of CRMP-1 as a novel factor for actin assembly opens a new field of 
study on how this new factor can work conjunction with other known actin-binding 
protein to modulate Listeria actin tail dynamics. However, our identification of CRMP-1 
cannot fully explain the full mechanism Listeria uses to build the actin tail. There might 
still be more factors that need to be identified. Brieher and colleague showed that brain 
cytosol contains factors that can facilitate the growth of Listeria actin tail in an Arp2/3-
independent manner (Brieher et al., 2004). The CRMP-1 function in our assay seems to 
be purely Arp2/3-depndent. While repeating the experimental procedure described by 
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Brieher, we did not detect an enhancement of Arp2/3-independent tail growth in the 
presence of CRMP-1 or CRMP-1 + EVL (Fig. 3 B). This missing factor might possibly 
be a small molecule, since it stays active after heating treatment and organic-solvent 
treatment (William M. Brieher, private conversations). Now we know CRMP-1 
contributes to actin tail formation. We also know CRMP-1 is a protein that is highly 
identical with DHPase regarding to their primary sequences and tertiary structures. 
DHPase can metabolize pyrimidine. It would be intriguing to know if the small molecule 
pyrimidine is the missing factor, which work through CRMP-1 to promot Arp2/3-
independent tail elongation. It would be worth testing if CRMP-1 can bind to pyrimidine, 
and whether the activity of CRMP-1 on Listeria actin tail formation would change upon 
this binding. Maybe CRMP-1 can contribute to Arp2/3-independent tail growth in the 
presence of pyrimidine. 
        CRMP-1 is one member of a family of five related proteins (Fukada et al., 2000; 
Hamajima et al., 1996; Wang and Strittmatter, 1996). We detected CRMPs can facilitate 
ActA-Arp2/3 reaction to different extends (Fig. 5). For example, CRMP-3 has a powerful 
effect; yet CRMP-2 does not seem to potentiate this reaction. CRMP family protein can 
form hetero-tetramer (Deo et al., 2004; Wang and Strittmatter, 1997). Researches showed 
CRMP might functionally antagonize to one another (see Chapter 1.V.iii). It is possible 
that the CRMP family proteins cooperate all together. They tune their ability of 
facilitating actin assembly through making hetero-oligomer with different combinations.   
        This study also provides the first-hand evidence on CRMP-1 functioning in 
regulating the F-actin amount inside mammalian cells. This phenomena was detected in 
two different cellular locations, at the cadherin-mediated cell-cell contacts (Fig. 12) and 
at the leading edge of lamellipodia (Fig. 10). Both of the structures are Arp2/3-dependent. 
WAVE-2 and N-WASP, the canonical Arp2/3 NPF that contains VCA/VVCA peptide, 
have been shown to activate Arp2/3 at these two cellular localizations, respectively. Yet 
we failed to detect the ability of CRMP-1 to enhance actin polymerization in a VCA- or 
VVCA-dependent manner (Fig. 16). We envisage that CRMP-1 works conjunction with 
EVL to activate Arp2/3 complex at this two cellular locations. Consistent with our 
speculation, this two proteins have to be present simultaneously in order to activate 
Arp2/3 complex in pure solution (Fig. 16). Perturbing the function of either one of them, 
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by knockdown approach or by dominant-negative construct, would reduce F-actin 
amount at those cellular locations (Fig. 17, 22 & 23). The phenotype of CRMP-1 
knockdown and/or EVL knockdown MDCK cells perfectly photocopy the Arp2/3 
knockdown cells (Fig. 12 & 17). In addition, blocking CRMP-1 activity alone on the 
purified membrane abrogates de novo Arp2/3 dependent actin assembly (Fig. 15). Those 
results demonstrated that CRMP-1 and EVL are important factors for actin assembly in 
the mammalian system. Our results also reveal a whole new pathway to regulate Arp2/3 
activity inside the cell. 
        While disturbing CRMP-1, EVL or Arp2/3 inside the cultured MDCK cells, we 
observed interesting changes in morphology. Perturbing other factors that contribute 
junctional actin assembly could also change cell morphology, yet not the same as the 
knockdown cells we show here. Cortactin, for example, is a protein that binds to WAVE-
2 and Arp2/3 to modulate actin assembly at adherens junction. Perturbing cortactin 
function would change cell morphology: irregular outlines and long cellular extensions 
(Han et al., 2014). CRMP-1 knockdown cells, however, maintain regular cobblestone 
morphology characteristic as wildtype MDCK cells, even though the F-actin amount is 
reduced (Fig. 12). It would be interested to know why interfering different pathways of 
activating Arp2/3 complex could cause different dissertations of epithelial cell 
morphology. It is possible that the actin network initiated through WAVE-2 or CRMP-
1/EVL is structurally distinct or functionally different. From a molecular basis, cortactin 
enhances Arp2/3-driven actin polymerization through a canonical WASp/WAVE-
dependent pathway; whereas CRMP-1 works with EVL to activate Arp2/3. It is possible 
that the two pathways response to different upstream signals and/or build different actin 
networks which then contribute to the organization of different cell morphology. 
Another interesting feature of our knockdown cells is that CRMP-1 knockdown cells 
displayed enlarged apical surface area with overall shorter in height (thinner in z-axis) 
(Fig. 12). This phenotype can be explained by different aspects.  
        First, apical surface of epithelial cells has been shown to be constricted by 
actomyosin network at the medioapical surface (Martin et al., 2009). The missing actin 
network under CRMP-1 knockdown condition is possibly as part of the actomyosin 
meshwork. As a consequence, insufficient amount of actin-mysoin network fails to 
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coalesce myosin and contract the meshwork in order to generate force to “close” the 
apical surface. Secondly, during epithelial cell polarization and maturation, it has been 
believed the stable cell-cell contact is required prior to junction maturation and cubical 
morphology development. The weaker and easer dissociated adhesion under CRMP-1 
depleted conditions (Fig. 19 & 20) implying the cell-cell contacts might fail to or might 
be less efficient to reach its ultimate stable stage to support the sequential maturation 
steps. The acquisition of the full polarity takes place while neighboring cells would 
compact towards each other. Yet CRMP-1 knockdown cells showed loosely organized 
cells even under confluent condition (Fig. 12), which provides another explanation to 
why those cells fail to form a tall cubical shape.  
        Live cell-imaging of CRMP-1 knockdown cells reveals its erratic migration during 
wound closure (Fig. 27). During wound closure, the whole sheet of cells behind the 
wounded edge undergoes collective migration, which is a process that a group of cells 
moves in concert without separating from each other. Since cell-cell contacts is one of the 
factors that contributes to cells moving collectively, and since cell-substrate adhesion also 
plays a role during cell migration, we suspected that the cell sheet formed by CRMP-1-
depleted cells become more motile due to: 1) reduced spreading ability to provide 
sufficient surface area (Fig. 22) in order to connect to the substrate, and 2) reduced cell-
cell adhesion (Fig. 19 & 20) to constrain the shifting.  
        The CRMP family is implicated in altering cell motility in response to regulatory 
signals (Goshima et al., 1995; Hedgecock et al., 1985; Inagaki et al., 2001).  CRMP-2, for 
example, is necessary for neuronal growth collapse in response to Semaphorin 3A 
(Goshima et al., 1995). My result on Sema3A and MDCK morphology is very 
preliminary (Fig. 25). Many control needs to be done in order to clarify if Sema3A can 
regulate MDCK cell biology. If future experiments demonstrate Sema3A can alter 
MDCK morphology, then our results here provide a mechanism for understanding how 
the CRMP proteins might alter cell motility in response to migration guidance: through 
regulating Arp2/3-dependent actin assembly.   
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CHAPTER 6: FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Data published in Yu-Kemp and Brieher, Journal of Biological Chemistry (2016): 
Fig. 1, 2, 4, 7 and 9. 
 Data used in manuscript for submission to Journal of Cell Biology: Fig. 10 A, 10 
B, 12, 14, 15 A, 15 C, 15 D, 16 (except K), 17 A, 17 C, 17 D (partial), 23 C 
(partial). *see Appendix A.* 
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Fig. 1. CRMP-1 is purified from brain cytosol as a factor that enhances Arp2/3-
mediated Listeria actin cloud formation. (A) Schematic representation of the meth-
od to identify factors that associate with Listeria and facilitate Arp2/3-dependent actin 
cloud formation. (B) Silver stained gel summarizing the purification of CRMP-1 from 
brain cytosol. (C) Mass spectrometry result of the last duplet band in (B). Peptides 
higlighted in gray were identified in both bands.  Peptides highlighted in purple 
were only identified in the upper band. The peptide highlighted in teal was only 
found in the lower band.  
Images: courtesy of William M. Brieher. 
Figure 1 
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Fig. 2. Preincubation of CRMP-1 with Listeria can boost  Listeria actin cloud for-
mation. (A) Coomassie gel with pur ified recombinant His-tagged human CRMP-1. 
(B) Recombinant CRMP-1 potentiates Arp2/3-dependent cloud formation. Field of Lis-
teria preincubated with buffer (top), or with recombinant CRMP-1 (bottom), using the 
method described in  Fig. 1. Listeria were labeled with DAPI and pseudo-colored in 
bule. FITC-labeled actin was pseudo-colored in red. (C) Dose-dependent effect of 
CRMP-1 on Listeria actin cloud formation. Scale bar: 20  m. 
Image (B): courtesy of William M. Brieher. 
Figure 2 
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      Set #            Experimental Setup                
       a.                    Arp2/3 + red actin             —> Wash —>        Arp2/3 + green actin   
       b.             Arp2/3 + red actin +CRMP-1   —> Wash —> Arp2/3 + red actin +CRMP-1 
a 
b 
Fig. 3. CRMP-1 successfully facilitates actin tail formation when CRMP-1 is pro-
vided in reaction buffer, without preincubation with the Listeria.  (A) Listeria  grew 
longer actin tails in the presence of CRMP-1. (B) Cyto D blocks actin polymerization on 
Listeria even in the presence of CRMP-1 and Arp2/3. Scale bars are 20  m. 
  a.            Arp2/3 + red actin +CRMP-1   —> Wash —> Arp2/3 + red actin +CRMP-1 
  b.  Arp2/3 + red actin +CRMP-1   —> Wash —> Arp2/3 + red actin +CRMP-1+CytoD 
a 
b 
Figure 3 
(A) 
(B) 
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Fig. 4. CRMP-1 is essential for  Listeria actin cloud formation. (A) Western blot 
(WB)against CRMP-1 indicating the amount of endogenous CRMP in brain cytosol and 
the efficiency of the immunodepletion. (B) Immunodepleting CRMP-1 from brain cyto-
sol decreases actin tail formation. Blue: DAPI-labeled Listeria; green: fluorescent-
labeled actin. (C) Quantifications of (B). Scale bar: 20  m. 
(A) 
Figure 4 
WB: CRMP-1  
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Experimental      Step 1                 Step 2                          Step 3 
  Condition         Preincubation      Initial Nucleation       Elongation/Nucleation 
      a.                 EVL                    Arp2/3 + dim actin   Arp2/3 + br ight actin   
      b.                 EVL                    Arp2/3 + dim actin         br ight actin 
(A) 
a b 
(B) 
Experimental     Step 1                Step 2                         Step 3 
  Condition       Preincubation     Initial Nucleation       Elongation/Nucleation 
      a.               EVL                    Arp2/3 + red actin         green actin   
      b.              CRMP-1              Arp2/3 +  red actin         green actin 
      c.              CRMP-1 + EVL   Arp2/3 +  red actin          green actin 
a b c 
Fig. 5. CRMP-1 does not support Arp2/3-independent actin tail growth in a prein-
cubation assay. (A) Three step preincubation assay shows that continuous supply 
of Arp2/3 is essential for effective tail growth. Listeria was preincubated with 125 nM 
EVL in step 1. To initiate the actin tail, the preincubation solution was replaced with 
Arp2/3 and dim actin (step 2). To test the role of Arp2/3 for tail elongation, the nucle-
ating solution was replaced with a solution containing bright actin in the presence 
(condition a) or absence (condition b) of Arp2/3 (step 3). Red: actin (dim or bright); 
blue: Listeria. (B) CRMP-1 cannot elongate tail in the absence of Arp2/3 complex. In 
step 1, Listeria was preincubated with 125 nM EVL, 125 nM CRMP-1, or CRMP-1 plus 
EVL (step 1). To initiate the actin tail was initiated by replacing the preincubation solu-
tion with Arp2/3 and the red actin (step 2). For the elongation the actin tail, green actin 
was provided after the removal of the nucleation solution (step 3). Red and green: actin; 
blue: Listeria. Scale bar: 5  M.  
Figure 5 
 74 
 
(A) 
(B) 
(C) 
Figure 6 
Fig. 6. Recombinant CRMP-1 shifts to a higher buoyant density fraction in brain 
extract. (A)-(C) Western blotting against CRMP-1 in the fractions from sucrose gradi-
ent. Left to right: low sucrose concentration to high sucrose concentration. (A) The dis-
tribution profile of recombinant CRMP-1 alone. (B) The distribution profile of recombi-
nant CRMP-1 after incubating one hour in brain extract. Note that we lost CRMP-1 sig-
nal in low-sucrose-gradient fractions. (C) The distribution profile of endogenous CRMP
-1 in brain extract.  
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Fig. 7. CRMP-1 facilitates ActA-Arp2/3 mediated actin polymerization. (A) & (B) 
CRMP-1 binds to ActA. (A) The image is a representative result from western blotting 
against CRMP-1. It shows the amount of CRMP-1 remaining in the supernatants after 
co-sedimentation with control or ActA beads. The initial amount of CRMP-1 provided 
to each reaction was labeled on the top of each panel. (B) The binding curve was gener-
ated from the average of three experiments.  Error bars are the mean values + s.d.  The 
affinity of CRMP-1 for ActA is 2.5  M. The gel is a representative western blot of the 
binding assay. (C)-(F): Pyrene assembly assay testing the role of CRMP-1 in actin 
polymerization: (A) CRMP-1 alone; (B) CRMP-1 and ActA; (C) CRMP-1 and Arp2/3; 
(D) CRMP-1 with Arp2/3 and ActA. In different testing conditions, we used the curve 
of ActA-Arp2/3 polymerization as a positive control. The curve of actin alone is the 
negative control. a.u., arbitrary units.  
Figure 7 (cont.) 
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Fig. 8. CRMP family members and DHPase enhance ActA-Arp2/3 polymerization 
differently. (A) Commassie gel showing the purified recombinant DHPase and dif-
ferent CRMP homologs. (B)-(E) Pyrene assembly assay testing the role of different 
CRMPs and DHPase in ActA-Arp2/3 actin polymerization: (B) CRMP-2; (C) CRMP-3; 
(D) CRMP-5; (E) DHPase.  
Figure 8  
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Fig. 11. CRMP-1 locates to cell-cell periphery during cell-cell contact formation. 
Calcium switch experiment indicating CRMP-1 signal appears at cell boundary while 
cell-cell contact starts to form. Scale bar: 10  m.  
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Figure 12 (cont.) 
Figure 12. Perturbing CRMP-1 or Arp2/3 function results in the loss of cortical ac-
tin and junctional actin. (A) Actin staining for  confluent MDCK monolayers of 
control cells (scramble) and the knockdown cells (CRMP-1 knockdown, Arp3 knock-
down or p34 knockdown). Scale bar: 50  m. (B)-(D) Quantification of (A). The 
amount of junctional actin (B) and cortical actin (C) decrease in the knockdown cells. 
For quantification, n=20. (D) Cell size on x-y plane. In this set of measurement, scram-
ble cells have average size around 282  m^2, which was standardized to 1 in the y-
axis. 25 cells were measured in each condition. (E) Western blotting indicates the 
knockdown efficiency.  
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Figure 13 
(C) (B) 
(A) 
Fig. 13. Perturbing CRMP-1 function results in the loss of stress fiber at the basal 
surface. (A) Phalloidin staining showing the loss of stress fiber  at the basal surface 
in CRMP-1 depleted condition. Stars: the loci of high-intensity actin alone the stress fi-
ber. Scale bar: 10  m, or as indicated. (B) & (C) Quantifications. (B) Reduced actin 
signal along the stress fibers in CRMP-1-depleted cells. (C) No significant change in the 
width of the stress fiber in CRMP-1 depleted cells. 
 86 
 
(A) 
Figure 14 
(B) 
(C) (D) 
Fig. 14. Arp2/3 might be less active in CRMP-1 depleted cells. (A) & (B) Quantifi-
cations of the amount of Arp2/3 (A) and alpha-actinin-4 (B) at cell-cell contact in 
scramble or CRMP-1-depleted cells. The quantification was done by analyzing the im-
ages acquired under fluorescence microscope after immunostaining of Arp2/3 and alpha
-actinin-4. Depletion of CRMP-1 results in a decreased amount of Arp2/3 and alpha-
actinin-4 at the junction. (C) & (D) Correlation of Arp2/3 (C) and alpha-actinin-4 (D) to 
actin. The correlation of actin to Arp2/3 changes in CRMP-1 knockdown background: 
less Arp2/3 per actin in the CRMP-1 depleted junction. Yet the correlation of actin to 
alpha-actinin-4 remains the same. 
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(C) 
Fig. 15 
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unscaled unscaled 
scaled scaled 
(D) 
Fig. 15. CRMP-1 controls actin assembly on adherens-complex-enriched mem-
brane. (A) Immunobloting of CRMP-1 indicates CRMP-1 associates with purified 
liver membrane fraction. The membrane were treated with high-salt solution prior to 
centrifugation. Lane P: pellet; lane S: supernatant. (B) CRMP-1 antibodies (CRMP-1 
Ab) do not block the recruitment of alpha-actinin-4 to the high-salt stripped membrane. 
(C) Actin formation at junctional-protein-enriched membrane is regulated by CRMP-1. 
CRMP-1 antibodies inhibited actin polymerization on the stripped membrane. Left: con-
trol. The images show the signal from fluorescent actin. Scale bar: 2  m. (D) Quantifi-
cations of (C).   
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Figure 18 
Fig. 18. Perturbing EVL function by shRNA or EVL dominant-negative constructs 
(EVL-DN) provides similar phenotype. Actin staining shows the reduced F-actin 
amount in both conditions. Scale bar: 20  m.  
EVL-DN EVL shRNA 
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Figure 20 
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Fig. 20. CRMP-1 depleted monolayers fail to maintain integrity after latrunculin 
treatment. E-cadherin staining for the monolayers of CRMP-1 knockdown or control 
cells under different conditions. The loss of the CRMP-1 knockdown cells after lant-
ruculin treatment implies the weaker cell adhesion under the knockdown background  
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Figure 21 
(A) 
(B) (C) 
Fig. 21. CRMP-1 localizes at the leading edge of lamellipodia.  (A) Immunostaining 
of CRMP-1 shows that CRMP-1 localizes to lamellipodia. Its signal colocalized with 
actin signal at the leading edge. Fixation method: formaldehyde fixation. (B) GFP-
CRMP-1 localizes to lamellipodia. (C) Immunostaining of CRMP-1 at lamellipodia. Fix-
ation method: TCA fixation. (D) TCA fixation and immunostaining indicates that 
DHPase can be detected in the leading edge. Scale bar: 10  m, unless indicated.  
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Figure 22  
Fig. 22. CRMP-1 regulates actin polymerization during cell spreading. (A) Per -
turbing CRMP-1 or Arp2/3 disrupts cell spreading on collagen. Images show phalloidin 
staining of actin in spreading cells. (B) Quantification of results from (A). Cells deplet-
ed of CRMP-1 are not included in the quantification for actin intensity since they do not 
make protrusions.  
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Fig. 23. CRMP-1 regulates actin polymerization at the wounded edge. (A) Wound-
ing MDCK II monolayers induces the formation of Arp2/3-dependent lamellipodia and 
Arp2/3 dependent actin cables. Wounded monolayers were treated with or without 
Arp2/3 inhibitors (100 nM CK-636 and 100 nM CK-548). Phalloidin staining showed 
that actin structures were greatly diminished around the wound edge in the presence 
Arp2/3 inhibitors. (B)  Phalloidin staining of actin and p34 subunit of Arp2/3 complex 
in wounded monolayers. (C) Quantifications of results from (B) indicated that overex-
pression of CRMP-1 resulted in higher actin signal Arp2/3 (p34) signal at the leading 
edge. For quantification, three repeats were done for quantifying the ratio of spreading 
cells or the ratio of cells with lamellipodia. KD: CRMP-1 knockdown; O/E: CRMP-1 
overexpression.  
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Fig. 25. Preliminary result shows that no attenuation of cell spreading or protru-
sive structure formation in the presence of Semaphorin 3A. (A) Exper imental set-
up. (B) &(C) Phalloidin staining showing the morphology of the cell in the presence or 
absence of Sema3A during (B) cell spreading and (C) wound healing. Scale bar: 20 
m.  
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Fig. 26. CRMP-1 contributes to the persistence of the protruding edge in wounded 
monolayers. (A) Representative kymograph of the protrusive edge. X-axis represent 
the time (minutes); Y-axis represents the distance ( m). Triangle indicates the start of 
the retraction. (B) Schematic representation of the parameters and the equation used for 
data analysis. (C) Leading edge of CRMP-1 knockdown monolayers exhibit high retrac-
tion frequency. CRMP-1 overexpressing cells protrude more persistent compared to 
wild-type and CRMP knockdown cells. WT: wild-type; KD: CRMP-1 knockdown: O/E: 
CRMP-1 overexpressing cells (O/E). * p<0.05. ** p<0.01. 
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Figure A.1 
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Figure A.1. CRMP-1 is expressed in epithelial MDCK cells and localizes to junc-
tional and cortical actin. Immunostaining of a confluent monolayers of MDCK 
cells showing that CRMP-1 (green) localizes with actin (purple) at cell-cell contacts, 
which are marked with E-cadherin (red).  CRMP-1 signal at this location can be detect-
ed in the apical surface of the young monolayer (1st day of confluency) (upper panel), 
the old monolayer (6th day of confluency) (middle panel), but not at the lateral mem-
brane. Blue arrowheads indicate the apical membrane; pink arrowheads indicate the lat-
eral membrane. CRMP-1 can be detected at the basal surface of the cell, yet its signal 
does not colocalize with any specific actin structures (lower panel). Scale bar: 10 m. 
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Figure A.2 (cont.) 
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Figure A.2 (cont.) 
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Figure A.3 
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Figure A.3 (cont.) 
Figure A.3. CRMP-1 works with VASP family proteins to facilitate actin polymeri-
zation.  (A) CRMP-1 does not contribute to Arp2/3 polymerization in the presence of 
constitutively active WAVE truncations. Left panel: VCA-induced Arp2/3 reaction; 
right panel: 273-induced reaction. The 273 construct contains VCA and proline-rich 
domain of WAVE-2. (B) CRMP-1 does not facilitate Arp2/3 polymerization mediated 
by VVCA of N-WASP. (C) Immunobloting of CRMP-1 on liver plasma membranes. 
(D) & (E) CRMP-1 contributes to  EVL-mediated actin polymerization. Increasing con-
centration of EVL was provided at the beginning of the reaction, a constant amount of 
CRMP-1 was added later (D). CRMP-1 provides a dose-dependent effect when the reac-
tion was started with a constant amount of EVL (E). (F) CRMP-1 promotes actin 
polymerization with the EVH2 domain, but not the EVH1 domain, of EVL.  (G) Provid-
ing both CRMP-1 and EVL at the beginning of actin polymerization do not increase the 
rate of actin polymerization. (H) CRMP-1 interacts with EVL. The binding curve of 
CRMP-1 to MBP-tagged EVL. (insert) western blotting of CRMP-1 in the supernatants 
showing CRMP-1 depletion after incubating with different amount of  EVL.  Numbers 
above each lane indicate total protein concentration on the beads. (Concentration: EVL 
was calculated as tetramer; MBP alone was calculated as monomer). (I) EVH2 of EVL 
interacts with MBP-tagged CRMP-1, but EVH1 domain does not. The coomassie stain-
ing shows the amount of EVL truncates remaining in the supernatant after incubating 
with the immobilized MBP or MBP-tagged CRMP-1.  (J) CRMP-1 has affect on VASP-
mediated (left) or MENA-EVH2-mediated (right) actin polymerization. Blue arrowhead 
indicates the time when CRMP-1 was added into the reaction.  
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Data Set #1 
Data Set #3 
Data Set #2 
Set # 1  2  3      1  2  3      1  2  3      1  2  3      1  2  3      1  2  3 
Condition # of filaments 
Actin alone 155 
+CRMP-1 132 
+EVL 141 
+EVL + 40 nM CRMP-1 147 
+EVL + 460 nM CRMP-1 128 
+EVL +80 nM CRMP-1 160 
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(B) (C) 
Figure A.4  
114 
 
0  180  90  
2.5  
0 
0  180  90  
2.5  
0 
0  180  90  
2.5  
0 
L
e
n
g
th
 (

m
) 
actin alone 
0  180  90  
2.5  
0 
    +EVL 
+CRMP-1 
+EVL 
+40 nM CRMP-1 
 
Figure A.4 (cont.) 
Figure A.4. Single filament experiments show that CRMP-1 facilitate EVL-
mediated actin elongation.  (A)  Quantitative result of single filament exper iments 
showing that CRMP-1 further increases the length of EVL– bounded filament. The fila-
ment were first polymerized with actin alone or in the presence of CRMP-1 or EVL for 
1 minute in the test tube. Different concentrations of CRMP-1 were added into EVL pre-
polymerized reactions. The reaction were immediately applied on a coverslip and rec-
orded for 3 minutes, with 3 second per frame. The length of the filaments grow in differ-
ent conditions were quantified. Three repeats were done, as shown in the plot as set #1, 
#2 and #3. (B) Quantification shows that CRMP-1 increases filament elongation rate in 
the presence of EVL.  (C) CRMP-1 and EVL might not nucleate actin filament, since 
similar number of filaments was detected for different conditions. (D) Representative 
kymographs from single filament experiments. 
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(H) 
Figure A.5. CRMP-1 and EVL regulates the amount of actin in MDCK cells. (A) 
Western blotting results indicate that MDCK cells express EVL and VASP. (B) MENA 
is not expressed in MDCK cell. The two blots showed the result  from using two com-
mercial antibodies. WT: wild-type cells. X indicates the amount of  whole lysate loaded 
into the well. For example, 2X means double volume of the sample were loaded. 1X 
contains approximately 150  g of protein. (C) CRMP-1 and EVL locates to cell-cell 
border. Red: cadherin; green: CRMP-1 or EVL. Scale bar: 10  m. (D) VASP does not 
show specific localization in the wildtype cell. (E) In CRMP-1 knockdown cells, VASP 
still has no specific localization; yet EVL is still at the junction. (F) EVL shRNAs are 
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Figure A.5 (cont.) 
117 
 
scramble CRMP-1  EVL  
(A) CRMP-1 actin merge 
EVL actin merge 
(B) 
knockdown knockdown 
EVL  
knockdown 
VASP  
knockdown scramble 
+VASP  
rescue 
Figure A.6. CRMP-1 and EVL contribute to the lamellipodia formation in MDCK 
cells. (A) Immunostaining showing that CRMP-1 and EVL localize to the leading 
edge of the protruding structures in response to wounding. (B) Phalloidin staining shows 
that in CRMP-1 or EVL depleted cells, the formation of lamellipodia was perturbed. (C) 
Quantification of (B) shows that the amount of lamellipodia formation is greatly re-
duced in the knockdown cells. (D) Depletion of VASP did not affect lamellipodia for-
mation. VASP did not rescue  EVL-depleted cell regarding to its ability of forming la-
mellipodia. Scale bar: 20  m.  
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Fig. B.1 MDCK cells express different CRMPs. (A) RT-PCR analysis of CRMP fam-
ily proteins in MDCK cells. (B) Depletion of CRMPs or DHPase in MDCK affects cell 
size. 
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Figure. B.1 
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(A) (C) (B) 
Fig. B.2. Purification of recombinant CapZ. Coomassie gel shows CapZ in (A) total 
lysate, (B) fractions after hydroxyapatite column, and (C) fractions after Q column.  
Figure. B.2 
